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Abstract 
	  
Brian L. Reger 
 
Background: Arterial dysfunction, due in part to arterial stiffening, is recognized 
as a surrogate end point for cardiovascular disease (CVD) and predicts the risk 
of future CV events. The metabolic syndrome (MetS) is a clustering of risk factors 
associated with increased stiffening and carotid artery thickening. Aerobic 
exercise is a well-established therapy that reduces CV events, and has proven to 
be an effective intervention against arterial stiffening and pathological wall 
remodeling in the healthy, hypertensive, and diabetic population. 
 
Aims: The purpose of this thesis was to examine the impact of aerobic exercise 
training on arterial stiffness and wall remodeling in MetS individuals. We 
hypothesized that an 8-week exercise intervention would decrease stiffness and 
reduce carotid wall thickness, compared to inactive MetS participants. 
 
Methods: We compared arterial stiffness (pulse wave velocity: PWV), carotid 
wall thickness (cIMT), central pulse pressure (cPP), and peak aerobic capacity 
(VO2peak) between healthy subjects (n=15) and MetS individuals (n=21), free of 
CV events. Further, we examined how 8 weeks of aerobic exercise training in 
MetS individuals (n=11) altered the above parameters, compared to MetS 
individuals (n=9) who remained inactive. Two MetS participants did not finish the 
8-week intervention and were only included in the baseline analysis. Cross-
sectional comparisons were analyzed using two-tailed independent t-tests. The 
intervention data was analyzed using repeated measures analysis of variance. 
 
Results: Carotid-femoral PWV (PWVcf) and cPP were 26% (P=0.001) and 33% 
(p<0.05) higher, respectively; in MetS individuals compared to healthy controls, 
and cIMT was 13% (p<0.05) greater in the MetS group. There was no significant 
difference between the trained and non-trained group in all baseline indexes. The 
major finding of this study was that 8 weeks of aerobic exercise significantly 
attenuated PWVcf (8.1 ± 0.5 vs. 7.2 ± 0.4 m/s, p<0.05) in the trained group, and 
no change was observed in the non-trained group (8.0 ± 0.5 vs. 7.9 ± 0.3 m/s, 
p=0.51). Carotid IMT did not change in the trained or non-trained group (0.58 ± 
0.03 vs. 0.58 ± 0.03 mm, p=0.78 and 0.59 ± 0.05 vs. 0.61 ± 0.05 mm, p=0.92). 
Another discovery was the trained group increased VO2peak (16.0 ± 1.4 vs. 18.2 
±1.7 ml/kg/min, p=0.05), and no change was seen in the non-trained group (19.0 
± 1.9 vs. 18.7 ± 1.3 ml/kg/min, p=0.76). Further, PWVcf and cPP were both 
negatively correlated (r=-.40 and r=-.51, p<0.01 for both) with VO2peak. 
 
 
Conclusions: Although the mechanisms underlying the improvement in arterial 
elasticity are not fully understood, there is strong evidence supporting an 
association with the improvement in peak aerobic capacity. Cross-sectional 
examination revealed increased stiffening and blunted VO2peak in the MetS 
individuals. Negative correlation was established between composite measures 
of stiffness and VO2peak. Following the aerobic exercise intervention, the trained 
group improved cardiorespiratory fitness, while reducing arterial stiffness. These 
are novel findings that indicate chronic, aerobic exercise is an effective 
therapeutic intervention that decreases arterial stiffness, but does not attenuate 
carotid wall thickening in the MetS. 
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Chapter 1 
 
 
 
 
Introduction 
1.1. Purpose 
 
 
Arterial stiffness is a term used to describe the elasticity and rigidity of the arterial 
wall and is commonly caused by fracture and fragmentation of elastic lamellae, 
increased collagen concentration, vascular smooth muscle cell (VSMC) 
hypertrophy, and endothelial dysfunction (responsible for increased VSMC tone) 
[1-4]. The main function of the central arteries is to act both as a conduit, 
delivering blood to the peripheral tissue, and a cushion, buffering pulsatile 
ejection of blood from the heart in order to provide constant flow to organs [5]. In 
a stiffened artery the buffering capacity is attenuated, resulting in an increased 
risk for cardiovascular disease (CVD) [6, 7]. The metabolic syndrome (MetS) is a 
clustering of risk factors associated with the increased risk of CVD [8]. These risk 
factors include; elevated blood pressure (BP), high triglycerides, low high-density 
lipoprotein (HDL) cholesterol, hyperglycemia, and abdominal obesity. The MetS 
is associated with increased arterial stiffening [8, 9]. In addition, carotid intima-
media thickening (IMT) is linked to arterial stiffness [10], and MetS individuals 
have been shown to have increased carotid thickening [11].  
The purpose of this thesis is to examine the impact of aerobic exercise training 
on arterial stiffness and wall remodeling in individuals with the MetS. It has been 
shown previously that aerobic training in older, healthy people (previously 
sedentary) and hypertensive subjects can attenuate stiffening [12, 13]. It is also 
our goal to evaluate the effect of aerobic exercise training on carotid IMT in MetS 
individuals. Aerobic exercise intervention improved endothelial function and 
reduces IMT in older, previously sedentary adults [14]. However, no study has 
examined the effect of exercise on carotid IMT in MetS individuals.  
1.2. Specific Aims & Hypothesis 
 
Specific Aim #1: Determine the effect of 8 weeks of aerobic exercise training on 
arterial stiffness in individuals with the metabolic syndrome. 
• Hypothesis #1: Individuals with the metabolic syndrome who exercise 
for 8 weeks will exhibit a decrease in arterial stiffening, compared to 
inactive participants.  
 
Specific Aim #2:	  Determine the effect of 8 weeks of aerobic training on carotid 
intima-media thickening in individuals with the metabolic syndrome.	  
	  
• Hypothesis #2: Individuals with the metabolic syndrome who exercise 
for 8 weeks will exhibit a decrease in carotid intima-media thickening, 
compared to inactive participants. 
	  
1.3. Background and Significance 
  
CVD is the leading cause of morbidity and mortality in modern societies, 
responsible for 2.4 million deaths every year [15]. People with the MetS are 3 
times more likely to die of heart disease than their healthy counterparts [16]. It is 
estimated that one-fourth of the American population, over the age of 18, have 
the MetS [17]. MetS is defined by the presence of three or more of the following 
traits; abdominal obesity, low HDL cholesterol, elevated triglycerides, 
hyperglycemia, and hypertension [18].  
Arterial stiffening, known as arteriosclerosis, is defined by lumen enlargement 
with wall thickening (remodeling) and a reduction of elastic properties (stiffening) 
[10]. It is a natural consequence of aging due to repetitive strain imposed on the 
arteries, and is increasingly recognized as a surrogate end point for CVD [19]. 
Arterial stiffness is increased in Mets individuals [20, 21], which may explain the 
increase in CVD associated with this syndrome [22]. Following ejection of blood 
from the heart, a pressure wave precedes the flow of blood and in a perfectly 
elastic aorta the reflected wave returns to the heart during diastole, when the 
aortic valve is closed [6]. This minimizes the pressure load imposed on the heart 
and increases pressure during diastole, when the coronary arteries are perfused 
[6]. The cushioning action of the central arteries is impaired in a stiffened artery, 
increasing the workload on the left ventricle (LV) and decreasing the efficient 
relationship between the arteries and heart [6]. Progressive stiffening of the 
arteries can occur with advancing age, mainly due to the structural and functional 
changes of the central arteries [5, 23]. 
Central pulse wave velocity (PWV), using applanation tonometry, is considered 
to be the gold standard for assessing arterial stiffness, non-invasively, and has 
been shown to be predictive of CV events [24]. PWV represents the time taken 
by the pulse to travel between two points of known distance, usually the carotid 
and femoral arteries [10]. In addition, evaluation of central pulse pressure [(cPP) 
(systolic BP (SBP) – diastolic BP (DBP))] and augmentation (AIx) provides an 
assessment of arterial stiffness, representing the cushioning capacity of the 
arteries and timing of the wave reflections, respectively [25]. Increasing SBP as a 
result of a stiffened vessel, results in an increase in cPP due to less elastin and 
more collagen activated at higher dispensability pressures. Hypertension, a MetS 
component, places an increased strain on central arteries through arterial 
remodeling [5]. 
Elastin fiber fracture and fatigue is a structural disturbance observed in a 
stiffened artery [6]. In a healthy, young person central arteries are composed of 
more elastin content, relative to collagen, enhancing the cushioning of blood flow 
and reflective waves toward the heart [26]. With aging, repetitive contractile strain 
reduces the amount of elastin and increases less distensible, collagenous fibers, 
in the proximal arteries [26]. VSMC hypertrophy, an increase in cell size, and 
increases in advanced glycation end products (AGEs) also contribute to arterial 
stiffening by cross-linking with the less elastic collagen fibers [27]. Functional 
arterial stiffening can be linked to an increase in VSMC tone, hypertension, and 
endothelial dysfunction [28]. Both sympathetic activity and endothelial derived 
factors influence VSMC tone and contributes to the progression of stiffness in 
MetS individuals [28]. The endothelium is a single layer of cells that line the 
arteries and release the potent vasodilator, NO [29]. NO suppresses VSMC 
contraction and prevents adhesion of platelets and monocytes that lead an 
increase in CVD risk [30]. It has been show that MetS patients suffer from 
endothelial dysfunction, mainly due to the decrease in NO bioavailability [31]. 
This decrease in vasodilator capacity and migration protection can increase wave 
pressures and wall hypertrophy, increasing arterial stiffness. 
In a stiffened aretery, an increase in the pressure wave places more tension on 
the microcirculation, and early reflection, due to decreased arterial elasticity, 
increases the workload on the LV [5]. This failure to cushion pulsations results in 
an increased risk for renal disease and stroke [32, 33]. The increased workload 
on the heart can lead to the development of an enlarged heart, left ventricle 
hypertrophy (LVH), increasing the risk for heart failure and myocardial infarction 
[5]. Finally, in a healthy artery the return of the pulse wave during diastole boosts 
perfusion to the coronary arteries. In a stiffened artery the earlier return can 
decrease coronary perfusion, increasing the risk of myocardial ischemia [6]. 
Exercise training is a well-established therapeutic intervention, and effective 
physiological stimulus that reduces CV related events and the possibility of 
developing CVD [34-36]. Regular aerobic training is associated with less 
stiffening of the large arteries in healthy adults, compared to their sedentary 
counterparts [37]. More importantly, regular aerobic exercise has been shown to 
reverse some of the arterial stiffening imposed in previously sedentary, middle-
aged and older men [25]. Aerobic training has also improved arterial elasticity in 
type II diabetics and hypertensive individuals; along with the improvement in 
endothelial function and reduced IMT [38, 39]. Studies have also shown that 
MetS patients who implemented an exercise-training regime improved 
endothelial function [16, 40]. However, it is not known whether continuous, 
aerobic exercise training can attenuate arterial stiffness or reverse premature 
arterial thickening in MetS individuals.  
Several mechanisms may be responsible for the cardioprotective effects of 
regular aerobic exercise on stiffness of large arteries. These may include both 
systemic and/or local effects on the arterial wall, directly influencing wall 
thickness, endothelial function, and elasticity [41]. Continuous exercise increases 
localized shear stress, increasing NO bioavailability, improving endothelium-
dependent vasodilation [42]. Localized shear stress can also decrease 
vasoconstrictors, preventing VSMC tone and wall thickening [43]. Other studies 
have shown a systemic effect on endothelial function through an exercise regime 
of the lower limb improving vasodilation capacity in the upper limb [44]. Data on 
whether exercise training prevents, or reverses premature carotid IMT, are 
equivocal. One study showed that after 3 months of high-intensity aerobic 
exercise, carotid IMT was not decreased in a healthy, previously sedentary 
population [45]. However, another study of the same nature, looking at conduit 
artery IMT, showed a decrease in thickness after an 8 week intervention [2]. 
A primary public health concern is to understand the mechanisms by which the 
MetS is associated with CVD, and to establish appropriate prevention and 
intervention strategies. One possibility may be due to the increase in arterial 
stiffening observed in this population. Our goal is to examine the impact of an 
aerobic exercise intervention on arterial stiffness and wall thickness in the MetS 
population.  
	  	  
	  
 
 
 
Chapter 2 
 
 
 
 
Review of Literature 
 
 
 
 
 
 
	  
2.1. The Metabolic Syndrome and Cardiovascular Disease 
 
 
CVD is the leading cause of morbidity and mortality in modern societies [46]. 
Over 82 million, 1 in 3, Americans has some form of CVD [15]. Several 
conditions increase a person’s risk of developing CVD. These factors include a 
family history of premature coronary artery disease (CAD), hypertension, 
hyperlipidemia, high cholesterol, insulin resistance/hyperglycemia, smoking, as 
well as aging [47, 48]. Certain CVD risk factors occur together and are not 
independent of one another in their shared responsiveness to lifestyle 
modifications or increased physical activity [49, 50]. The MetS is a clustering of 
risk factors that lead to a high risk for the development of CAD, type II diabetes 
and CVD [51-54]. Individuals with the MetS are 3 times more likely to die of heart 
disease than the healthy population [16]. It is estimated that 56 million (24%) 
Americans, over the age of 18, have MetS and 45% of people over the age of 50 
have MetS [17, 52]. The MetS components include; abdominal obesity, low HDL 
cholesterol, elevated triglycerides, hyperglycemia, and hypertension [55]. Arterial 
dysfunction, due to arterial stiffening, is recognized as a surrogate end point for 
CVD and a number of studies point to stiffness predicting the risk of future fatal 
and nonfatal CV events [6, 7, 27]. The MetS has more advanced stiffening, when 
compared to their healthy counterparts [19, 22]. Carotid IMT, a non-invasive 
measurement of arterial wall thickness, was shown to increase 2-to-3 fold 
between 20 and 90 years of age in a population of 137 healthy, sedentary men 
[45]. A meta-analysis found that a 0.1 mm increase in carotid IMT is associated 
with an 18% increased risk for stroke and 15% for myocardial infarction [56]. 
Several studies have found that physically active men and women have a lower 
incidence of CVD compared with sedentary pears [36, 57, 58]. Regular aerobic 
exercise is associated with enhanced arterial compliance and greater endothelial 
function, especially in healthy middle-aged and older adults, that may be 
responsible for much of the CV protective role due to training [59]. 
 
2.1.1. Definitions of the Metabolic Syndrome 
 
 
Identifying those with increased metabolic risk components is important, because 
it categorizes people who are at a high risk of developing CVD and type II 
diabetes, such as the Framingham risk score and a diabetes prediction model 
[55]. The term identifies a specific subgroup of individuals with a shared 
pathophysiology, easily used between clinicians, recognizing an underlying 
biological process [55]. There are four commonly used definitions of the MetS, 
summarized in table 2.1 below. [60]. The World Health Organization (WHO) was 
the first definition, released in 1998 [61]. It tied together the key components of 
insulin resistance, obesity, dyslipidemia, and hypertension. It stated that insulin 
resistance must be present and even if all the other criteria were met, the 
individual would not have the MetS [61]. The European Group for the Study of 
Insulin Resistance (EGIR) released a modified definition in 1999 that defined 
insulin resistance levels, and stated that resistance, plus two other risk factors 
must be present [62]. The modification also excluded those with diabetes [55]. In 
2005 International Diabetes Foundation (IDF) published new criteria for MetS. 
The IDF does not require insulin resistance, but does stress the importance of 
weight distributions, recognizing central obesity as an important factor. The IDF 
definition is often criticized for its emphasis on obesity, rather than insulin 
resistance [63].  
 
The definition used during this study, according to the National Cholesterol 
Education Program: Adult Treatment Panel III (NCEP ATP III), is defined as the 
presence of three or more of the following traits: abdominal obesity, low HDL 
cholesterol, elevated triglycerides, hyperglycemia, and elevated BP [18]. It is one 
of the most widely used definitions because it incorporates measurements and 
laboratory results that are readily available to physicians and clinical researchers. 
It isn’t biased, because it does not require any one of the specific criterion to be 
met towards an underlying cause of MetS, just that 3 of the 5 are present [55].  
 
Table 2.1. Definitions of the metabolic syndrome 
        Criteria NCEP ATP III WHO EGIR IDF 
Requirements 3 of 5 criteria below Diabetes or IR, plus 2 of 5 criteria below 
High Insulin, plus 2 
of 4 criteria below 
Obesity, plus 2 of 4 
criteria below 
Obesity Waist >102 cm (M), >88 cm (W) 
Waist/hip ratio >0.9 
cm (M), >80 cm 
(W) 
Waist >94 cm (M), 
>80 cm (F) Obesity required 
Hyperglycemia Glucose >100 mg/dl IR required IR required Glucose >100 mg/dl 
Dyslipidemia TG >150 mg/dl TG >150 mg/dl TG >177 mg/dl TG >150 mg/dl or RX 
HDL Cholesterol HDL-C <40 mg/dl (M), <50 mg/dl (W) 
HDL-C <35 mg/dl 
(M), <39 mg/dl (F) HDL-C <39 mg/dl 
HDL-C <40 mg/dl 
(M), <50 mg/dl (F) or 
RX 
Hypertension 
>130 mmHg systolic 
or 85 mm Hg 
diastolic BP or RX 
>140/90 mmHg BP >140/90 mmHg or RX 
>130 mmHg systolic 
or >85 mmHg 
diastolic BP or RX 
* IR – Insulin Resistance, TG – Triglycerides, RX – Medicinal Treatment 
2.1.2. Normal Arterial Function 
 
 
Blood flows continuously, evenly, and uninterruptedly through the arteries of the 
body, whereas the heart’s action as a muscle pump is intermittent [6]. The central 
arteries play two important roles in its interaction with the LV, that of a conduit 
and a cushion. The first function is to deliver blood from the LV to the smallest 
arteries of organs and tissues, according to their needs. The second is to cushion 
the pulsations generated by the heart so that blood flow is continuous [5]. The 
large central arteries, particularly the aorta where elastin material is greatest, are 
very elastic and act as a reservoir during systole, storing part of the ejected 
blood, forcing it out into the peripheral arteries during diastole. A.V. Hill stated, 
“The amount of energy which the heart has to expend per beat other things being 
equal, varies with the elasticity of the arterial system” [6]. A healthy, compliant 
aorta results in an efficient heart and arterial interaction, minimizing any pressure 
increases imposed on the heart that would cause an increase in the workload.  
 
Following the systolic ejection of blood on the aortic wall, a pressure wave 
develops and is rapidly propagated from the LV down the arterial system [26]. 
When the forward wave reaches high-resistant arterioles a backward wave 
occurs as a consequence of wave reflection. The reflected wave summates with 
the forward traveling wave, creating a central pressure waveform. A healthy 
arterial system is most efficient when the proximal aorta is elastic, resulting in a 
wave reflection that returns during diastole, optimizing perfusion of the coronary 
arteries [6].  
2.1.3. Arterial Stiffness Defined 
 
 
The structure and function of the central arteries, particularly the aorta, change 
throughout the lifetime of humans. This arterial bed is elastic and compliant in a 
healthy individual, storing blood ejected during contraction of the heart and 
releasing it to the periphery during diastole. As a person ages the central arteries 
become less compliant [5]. Arterial stiffening, known as arteriosclerosis, is 
defined by lumen enlargement with wall thickening (remodeling) and a reduction 
of elastic properties (stiffening) [10]. In a healthy, young individual the PWV is 
approximately 3 to 5 m/s at rest, increasing 2-to-3 fold with age [37].  
 
Increased stiffness predicts the development of CVD and is associated with 
common diseases of aging, including stroke and renal disease [64-67]. Arterial 
remodeling contributes to most age-associated CV disorders including; systolic 
hypertension, increased cPP, LVH, diastolic dysfunction, stroke, atherosclerotic 
coronary and peripheral disease, congestive heart failure, and myocardial 
infarction [27, 68]. Arterial aging is believed to originate from alterations in cross-
linking of extracellular matrix components, elastic network degradation, and 
calcification of elastic fibers [10]. Stiffening of the large arteries reduces 
capacitance, contributing to the widening of cPP and the increased prevalence of 
systolic hypertension with age [47]. The chronic rise in central pressures 
increases the risk of carotid thickening, via hyperplasia and hypertrophy of VMSC 
and increased collaged deposition [69], further contributing to arterial stiffening. 
Enlargement of the large arteries with age, and increased pressures, is generally 
attributed to the fracture of load-bearing elastin fibers. The arterial wall remodels 
itself in response to long-term changes in increased pulsatile flow, such as the 
luminal diameter expands to maintain a constant, pre-determined, level of shear 
stress [70]. A previous study found a strong relationship between increased cPPs 
and both carotid wall thickness and lumen enlargement [71].  
 
2.2. Arterial Stiffness and Assessment Methods 
 
 
Central carotid-femoral PWV (PWVcf) represents the time taken by the pulse to 
travel between two points of known distance, and is a direct measure of arterial 
stiffness [10]. Arterial stiffening is associated with numerous CVD risk factors [47, 
48] leading many to believe that increased stiffness may be a surrogate marker 
for advanced atherosclerotic disease. However, prior studies have suggested 
that aortic stiffening can occur in the absence of atherosclerosis [25, 37]. A study 
conducted in China, where atherosclerotic disease is almost nonexistent, allowed 
the independent investigation of the effects of age and BP on PWV, without any 
or less significant contribution from atherosclerosis [25]. Both SBP and PP 
increased with age and were significantly related to PWV [25]. PWV was not 
related to serum cholesterol, which tended to be lower at all ages compared to 
that of Western populations. This indicates that aging, not atherosclerosis, is the 
dominant factor associated with reduced arterial compliance. 
 
DBP, mean arterial pressure, and peripheral BPs were considered to be a better 
guide of disease severity, but the paradigm has shifted over the past few 
decades, and many studies have shown cPP is increased with advancing age 
and is a stronger predictor of CVD risk [24, 47]. Central pressures are a 
representation of strain imposed directly on the heart [24]. In a population-based 
cohort of the Framingham Heart Study, Franklin et al. [72] demonstrated during a 
20-year follow-up period, that cPP rose steeply after the age of 50. In addition to 
PWV as a measure of arterial stiffness, simultaneous evaluation of the cPP 
provides an indirect assessment of stiffness [73]. cPP is the consequence of 
intermittent ventricular ejection from the heart and its main role is to minimize 
pulsatility in the central arteries [47]. The determinants of cPP are the cushioning 
capacity of arteries and the timing and intensity of wave reflections [26]. During 
pressure increases the elastic properties of the arterial media reach a point 
where less distensibility occurs [74]. At low pressure elastin fibers dominate the 
mechanical behavior and the arterial wall is very extensible. Whereas at higher 
pressure the tension is predominantly absorbed by the more rigid collagen fibers, 
reducing compliance [26]. Measurements of PWV should be corrected for the 
acute response of a rise in pressure.  
 
Applanation tonometry provides a non-invasive measure of central pulse 
waveform analysis (PWA), producing an AIx measurement [24]. The radial 
pressure wave is recorded and a validated generalized transfer function is 
applied to generate the corresponding central pressure waveform. AIx is a 
measure of systemic arterial stiffness, representing the percentage of cPP that is 
constituted by the augmentation pressure added to the systolic pressure peak, 
based on the reflected wave [24]. In a stiffened artery the quicker moving wave 
returns during the systolic ejection period, increasing the cardiac workload, which 
may overtime lead to LVH. A hypertrophied heart requires more oxygen and 
contracts more slowly, decreasing the duration of diastole, linking LVH to 
myocardial ischemia, angina, atrial fibrillation, and heart failure [75]. This 
decrease in diastolic period, along with a slower HR and earlier reflected wave, 
adds to the workload mentioned above. SBP is amplified by the early reflected 
wave and diastolic augmentation is reduced, decreasing DBP, leading to an 
elevation in cPP [74]. This shows cPP not only can lead to an increase in arterial 
stiffness, mainly acutely at higher pressures as the workload is pushed to the 
more rigid collagenous fibers, but also that a stiffened artery contributes to 
hypertension through a chronic increase in cPP. 
 
Ultrasound examination of the carotid artery IMT has traditionally been used to 
evaluate the presence of atherosclerosis [76]. More recently it has emerged as 
one of the most popular methods in detecting non-obstructive plaque and 
determining early arterial wall remodeling [76, 77]. Several studies have shown 
that increased IMT is a predictor of CV events [56, 76, 78]. IMT is increased in a 
number of CV risk factors including: diabetes, hyperglycemia, hypertension, 
obesity, and MetS individuals [11, 27, 79, 80]. More importantly, IMT occurs with 
aging, even in populations without incidence of atherosclerosis [81]. A thickened 
carotid artery is relevant in the discussion of arterial stiffening because of the 
changes that occur in arterial wall composition in a stiffened artery. Increased 
stiffness contributes to a greater rise in cPP [71]. The rise in central pressure 
increases the risk of carotid thickening, in response to insults via hyperplasia and 
hypertrophy of VMSC and increased collagen deposition [69]. 
2.3. Arterial Stiffness and Possible Mechanisms 
 
 
There are several structural and functional arterial changes that occur which 
influence arterial stiffening. Hypertension, one of the MetS criteria, accelerates 
arterial stiffening through both structural and functional mechanisms [26]. The 
increased pulsations caused by elevated BP places extra stress on the weight-
bearing elastic lamellae, resulting in central artery stiffening [82]. Acquiring 
additional knowledge about the structural and functional deviations of the arteries 
will provide an opportunity to develop therapeutic interventions with a specific 
target of action. 
 
2.3.1. Structural Arterial Stiffening  
 
 
Arteries stiffen with age principally because of elastin fiber fracture and the 
resultant increase in collagen/elastin ratio. In a normal functioning artery the 
amount of elastin material is predominately located in the central arteries, where 
it plays the key role of cushioning blood flow and pulse waves from the LV. This 
majority is reversed in muscular arteries, where there is a far greater amount of 
collagen [26]. As a result, carotid-radial (PWVcr) is greater at a younger vs. older 
age and doesn’t experience the increase in stiffening witnessed in the central 
arteries [6]. The proximal, elastic arteries and aorta dilate approximately 10% 
during ventricular contraction, as opposed to only 2% to 3% for the peripheral, 
muscular arteries [5]. Natural rubber with repetitive stretch of 10% will break after 
1 billion cycles, which corresponds to 30 years of a human life [6]. Therefore, an 
individual who lives to an age of 90 has experienced close to 3 billion 
contractions of the heart, and the same number of pressure loads imposed on 
the proximal arteries. The PWVcf reaches, and often exceeds, the value 
observed in muscular arteries with aging, and is accelerated in the MetS [21]. 
Increased central pressure acutely transfers the stress of the pulse wave from 
elastin material to less distensible collagenous fibers in the arterial wall, and 
chronically increases collagen production and AGE linkage to the extracellular 
matrix material. Many would argue then that stiffening is a natural consequence 
of aging and that the famous John Hopkins physician, William Osler, is correct in 
stating that “man is as old as his arteries [5].”  
 
In addition to the elastin fiber fracturing, and the outward wall remodeling 
observed in MetS patients, increased collagen concentration and cross-linking, 
VSMC hypertrophy, and increased growth factors are key mechanisms leading to 
structural changes in the intima-media layer that cause stiffening [27]. The 
amount of collagen is determined at a very young developmental stage and 
experiences very low turnover [26]. However, as presented earlier, repetitive 
pressure strains imposed on the arterial wall results in a proximal aortic collagen-
to-elastin ratio remodeling towards that of the more distal arteries. Several 
neurohumoral factors, particularly angiotensin II and aldosterone systems, 
modulate collagen accumulation. It has been shown in cell cultures, angiotensin 
II stimulates the production of various types of collagen, VSMC hypertrophy, and 
growth fibers [28]. Also, AGEs (proteins or lipids that become glycated after 
exposure to sugar) contribute to arterial stiffening by forming irreversible cross-
links between slow-turnover proteins such as collagen, and compromise 
endothelial function by decreasing NO and increasing the generation of oxidants 
[3, 4]. AGEs activate metalloproteinases (MMPs), initiating inflammatory 
responses that can increase arterial stiffness, further contributing to endothelial 
dysfunction and atherosclerotic disease promotion [83]. MMPs are enzyme 
producing proteins which control extracellular matrix components and when over 
expressed can lead to an increase in collagen and stiffening [84].  
 
2.3.2. Functional Arterial Stiffening 
 
 
Functional changes that have a role in arterial stiffness are increased VSMC tone 
(increased sympathetic nervous activity), high BP, and endothelial dysfunction 
[23, 85]. VSMCs don’t represent a homogenous population, they may have 
different contractile, proliferative, and apoptotic behavior [4]. The expression of 
each of the phenotypes depends not only on age, but also on the location in the 
arterial system and pathological conditions [26]. Changes in VSMC tone, causing 
arterial constriction or dilation, can occur directly or through signals from the 
endothelial cells, influenced by shear mechanical stress, as well as paracrine 
mediators such as angiotensin II, endothelin, and NO [26]. Increased 
sympathetic nervous system activity, present in aging and MetS patients, 
influences VSMC tone and the progression of arterial stiffness [86].  
 
The endothelium, made up of a single layer of cells that line the arteries, provide 
a critical barrier of protection between the blood and tissues [30]. The vasodilator 
NO, is released from the endothelium and limits clotting and inflammation, 
suppresses VSMC contraction, and prevents adhesion of platelets and 
monocytes that all contribute to arterial remodeling [29]. Traditional risk factors of 
endothelial dysfunction are hypertension, cigarette smoking, diabetes, age, 
hypercholesterolemia, and CAD; owing to decreased bioavailability of NO, mainly 
contributable to evidence of oxidative stress [87-92]. Recent studies have shown 
that this loss of endothelium-dependent vasodilation plays a key role in arterial 
stiffening [1, 93]. A proposed central event in the MetS is a decrease in the 
amount of bioavailability of NO from endothelial cells, increasing VSMC tone [23]. 
The increase in VSMC tone can alter the distribution of stresses between the 
elastic and collagenous fibers of the arterial wall and thus alter stiffness. 
Evidence also indicates that arterial stiffness itself may influence endothelial 
dysfunction, and NO release [94, 95]. A chronic increase in PP can potently alter 
the eNOS responses. The wall thickening that can occur in a stiffened artery 
poses a barrier to NO diffusion from endothelial cells, which may cause 
endothelial dysfunction [96]. Flow-mediated dilation (FMD) is an endothelium-
dependent process that reflects the relaxation of a conduit artery when exposed 
to increased shear stress, and is the method used in our study to observe 
functional stiffening. 
 
2.4. Cardiac Consequences of Arterial Stiffness 
 
 
In a stiffened aorta the reflected pressure wave returns earlier in the cardiac 
cycle, increasing the workload of the heart, resulting in LVH [5]. A hypertrophied 
heart requires more oxygen and becomes predisposed to ventricular systolic or 
diastolic heart failure, left atrial strain and enlargement, and atrial fibrillation [24]. 
Further, the hypertrophied heart contracts more slowly, the duration of systole 
lengthens, decreasing the length of diastole [5]. The coronary arteries are mostly 
perfused during diastole, and in a stiffened vessel the earlier return of the 
reflective wave during systole impairs perfusion, increasing the risk of myocardial 
ischemia [6]. Increased large artery stiffness most likely explains the fall in DBP, 
commonly observed after the age of 60 years or accelerated in MetS patients. 
The decline DBP is probably the result, rather than the cause of stiffening [97].  
 
Arterial stiffening also increases the risk for stroke and renal malfunction. The 
microcirculation is compromised mainly of smaller, resistance arteries that act 
primarily as conduits, not playing a role in cushioning [5]. As the central arteries 
lose elasticity with age and disease, the failure to cushion pulsations leads to an 
increase in pressure wave transfer to the peripheral organs, mainly the brain and 
kidney [98]. Severe lesions in the microcirculation of the brain and kidney are 
observed in older persons that include damage to the endothelium with 
thrombosis and inflammation of the media [32]. Therapeutic interventions that 
reduce stiffness improve small arterial function and decrease both cerebral and 
renal dysfunction, linking stiffness to microcirculation disease [33, 99, 100].  
 
2.5. Metabolic Syndrome and Arterial Stiffness 
 
As a result of CVD risk factor clustering, MetS patients often have arteries that 
have stiffened beyond their chronological age [19, 20, 22, 101]. It places this 
population at an increased risk of multiple diseases [102]. An important MetS risk 
factor, high BP, can have a drastic effect on arterial stiffening [21, 103]. This 
repetitive strain in MetS patients is greater than that of a disease free individual, 
causing greater elastin fiber fracture and less cushioning capability of the arteries 
[6]. Other risk factors associated with the MetS, hyperlipidemia and low HDL 
cholesterol, influence the functional capacity of the endothelium, which increase 
stiffness [104]. 
 
 
 
 
2.6. Aerobic Exercise and Arterial Stiffness  
 
Hippocrates taught, “positive health requires a knowledge of man’s primary 
constitution…There must also be exercise of which the effects must likewise be 
known…If there is any deficiency in exercise the body will fall sick” [34]. The 
teachings were based on inspiration and philosophy, without scientific evidence. 
However, the development and growth of physical activity research has proven, 
and continues to produce, various mechanisms of disease protection. Exercise 
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training is a well-established therapeutic intervention and effective physiological 
stimulus that reduces CV events and the possibility of developing CVD [34-36, 
105]. Exercise training has been shown to improve arterial function in healthy 
adults (previously sedentary), and hypertensive individuals, which relates to a 
decreased risk of CVD [2, 41, 44]. Arterial stiffness imposes a threat on arterial 
wall remodeling, increasing the incidence of CV risk factors, and influences the 
release of endothelial derived factors, affecting oxidative stress and 
inflammation, which has been shown to be attenuated with exercise [47]. Regular 
aerobic exercise has been shown to attenuate arterial stiffening observed in 
previously sedentary, healthy middle-aged and older men [50, 59]. Exercise also 
reduces artery wall thickness in other populations, associated with reduced rates 
of hypertension and other CV disease states [2, 45]. An important cardiac and 
arterial protective effect of exercise training may be explained by the effect of 
acutely elevated pulsations imposed on the arteries [106]. 
 
2.6.1. Aerobic Exercise and Arterial Stiffening In Other Populations 
 
 
The protective effect against arterial stiffness has been shown to be related to 
cardiorespiratory fitness [37]. Arterial stiffening was shown to be inversely related 
to aerobic capacity in healthy, endurance-trained and sedentary populations [25]. 
More importantly, in previously sedentary, healthy middle-aged and older men 
who underwent 3 months of aerobic exercise training, carotid artery compliance 
returned to levels observed in exercise-trained adults of the same age [107]. 
Multiple studies have shown that exercise training in younger endurance-trained 
individuals and older, previously sedentary adults, improved endothelial function 
and reduced IMT [2, 43, 106, 108, 109]. The Framingham Heart study showed 
that untreated hypertension may contribute to increased arterial stiffening and 
thus perpetuate a vicious cycle of accelerated hypertension and further increases 
in large artery stiffness [82]. A 3 week aerobic exercise protocol decreased 
arterial stiffness in both the carotid and femoral arteries in hypertensive type II 
diabetics [110]. The reduction occurred without any significant improvements in 
aerobic fitness, weight, body mass index (BMI), or BP.  
 
2.6.2. Aerobic Exercise and Arterial Stiffening In the Metabolic Syndrome 
 
 
Previous studies have shown that aerobic exercise and strength training 
improves endothelial function and capacity in MetS patients after 12 to 16 weeks 
[16, 40]. Whereas short-term (10 days) training had no effect on endothelial 
function or PWV in MetS individuals [49]. No difference was observed in FMD or 
PWV between MetS patients and healthy controls who trained [49]. However, an 
inverse relationship was identified between cardiorespiratory fitness and central 
stiffness in men with the MetS [111]. Therefore, it is believed that a longer 
duration of continuous, aerobic exercise will decrease arterial stiffness and 
carotid IMT in MetS individuals. No study has shown the effect of chronic aerobic 
exercise on carotid IMT or stiffness in the MetS. Previous studies have shown an 
attenuation of both after an 8-week intervention in other populations [38, 112]. 
 
 
 
 
2.7. Possible Mechanisms for Reduced Arterial Stiffness  
 
 
The mechanisms underlying the effects of regular aerobic exercise on large 
elastic artery stiffness are largely unknown, but are likely due to functional 
alterations, possibly due to improved endothelial function as already shown [16, 
40], or changes to the composition of the arterial wall [2]. The present study was 
not designed specifically to determine the mechanisms underlying the effects of 
regular exercise on arterial stiffness and remodeling. However, we hope that our 
data may provide insight into this question.  
 
2.7.1. Aerobic Exercise and Endothelial Function  
 
The cardioprotective effects of exercise training may be explained in part by the 
direct effects of repeated exercise bouts on the arteries, influencing endothelium-
dependent vasodilation [105]. In one study subjects were asked to perform a 
bilateral handgrip-training program, where one arm was occluded with a blood 
pressure cuff to simulate a decrease in blood flow and shear stress. The same 
exercises were performed in each arm, but vasodilator function, measured by 
FMD, was only enhanced in the limb exposed to increases in shear stress during 
the training bouts [106]. This confirmed that pulsatile flow, through shear stress, 
provides a physiological stimulus to NO production, promoting a decrease in 
inflammation and VSMC tone. Changes in shear stress also decrease the 
expression of vasoconstrictors, endothelin-1 and VSMC adhesion molecules, 
exhibiting an anti-atherogenic effect [106].  
 
However, it was also shown that lower limb exercise training improved 
endothelial function in the upper limb arteries [42]. This suggests, in addition to 
localized action, exercise training induces generalized systemic effects on 
endothelial function, either through an increase in circulating metabolic stimulus, 
anti-inflammatory response (antioxidant enzymes), or systemic hemodynamic 
changes [2, 42]. The capacity for NO vasodilator activity to increase in non-
exercised limbs indicates that acute exercise training is associated with a 
sustained and systemic favorable modification of arterial stiffness, at least in the 
short-term. Thus, acute increases in BP, and the consequent cyclic change in 
transmural pressure across the arterial wall, may contribute to functional 
adaptations [113]. In summary, NO activity in the resting arteries is enhanced 
through exercise-mediated, hemodynamic modulation in active tissues, 
influencing VSMC tone and altering the distribution of stresses between the 
elastic and collagenous fibers of the vessel wall [23]. 
 
2.7.2. Aerobic Exercise and Oxidative Stress  
 
Oxidative stress can influence endothelial dysfunction by suppressing the 
bioavailability of NO [30]. However, in low concentrations, free radicals are 
thought to act as mediators and modulators of cell signaling and are important in 
exercise-induced vasodilation. A recent study of human coronary resistance 
arteries showed that non-muscle mitochondrial respiration and oxidative stress, 
through an increase in exercise-related sheer stress and the consequent release 
of free radicals, is necessary for flow-mediated dilation to occur [114]. Oxidative 
stress is determined by the balance between pro- and antioxidant forces, and is 
likely a crucial aspect of life [115]. Richardson et al [116] implicated an exercise-
induced reliance upon pro-oxidant-stimulated vasodilation during an acute bout 
of exercise in young healthy men. They also showed that an oral antioxidant 
cocktail effectively reduced free radicals, disrupting the balance between pro- 
and antioxidant forces, decreasing the exercise-induced endothelial-dependent 
vasodilation [116].  In contrast, at high levels the superoxide (O2-) and other free 
radicals are believed to inactive NO, contributing to the progression of endothelial 
dysfunction and resultant increase in arterial stiffening [115].  
 
The increase in oxidative stress and inflammatory action observed in MetS 
individuals, can be attenuated with aerobic exercise training [117]. One study 
showed that aerobic exercise inhibited NADPH oxidase activity (increases 
reactive oxygen species) and up-regulated the antioxidant enzyme, superoxide 
dismutase, improving conduit artery dilation in old sedentary mice by increasing 
NO bioavailability [118]. Further, it was demonstrated that older men who 
exercise regularly do not demonstrate arterial endothelial oxidative stress, and 
oxidative circulating factors did not differ with young controls [119].  
 
2.7.3. Aerobic Exercise and Arterial Wall Remodeling  
 
 
Several studies have been performed looking at the effect of exercise training on 
wall thickness in different arterial locations, and have proven to be inconsistent in 
their findings. Thijssen et al. [2] showed that exercise training in healthy, 
previously sedentary, young men led to a decrease in conduit wall thickness due 
to systemic, rather than localized stimuli. However, several previous studies 
showed that training does not impact carotid artery thickness or diameter [45, 
120]. Tanaka et al. [45] performed a cross-sectional study inclusive of young and 
old people, comparing healthy, sedentary individuals to healthy, endurance 
trained athletes. They concluded that regular vigorous endurance exercise did 
not attenuate the age-associated increase in IMT [45]. An additional healthy, 
sedentary group was recruited to perform a 3-month aerobic exercise 
intervention and found that carotid IMT did not decrease after exercise [45]. One 
theory may be that SBP or cPP did not decrease following the exercise, which 
has been shown to have a major influence on arterial remodeling [10]. The length 
of exercise duration, extent of arterial thickening, and most importantly, the 
population observed must be considered. Only a healthy cohort, with no 
evidence of chronic diseases, has been studied. It is possible that regular aerobic 
exercise could have a beneficial effect on carotid IMT in MetS individuals with 
increased CV risk factors.  
 
2.8. Future Implications for Cardiovascular Disease 
 
The number of Americans over 60 will nearly double, from 57 million people in 
2000 to over 92 million in 2030, an increase from 18 to 25 percent of the 
population [121]. If the current trends hold true in the future, a similar increase in 
the prevalence of the MetS will most certainly occur. Thus, the incidence and 
prevalence of age-associated, arterial disease will increase dramatically. There is 
individual variability in arterial dysfunction and stiffening often associated with 
advancing age [20]. This suggests that several physiological and lifestyle factors 
have a great influence on arterial aging. Habitual aerobic exercise may be the 
single most important modulatory influence [46]. Many of the current 
therapeutics, including antihypertensive drug therapy and exercise training 
programs, were mainly designed to reduce peripheral resistance and are not 
adequately designed to alter the pathological process of central arterial stiffening. 
The goal of our research is to determine whether aerobic exercise training can 
attenuate arterial stiffening and wall thickness in MetS individuals.  
	  	  
	  
 
 
 
Chapter 3 
 
 
 
 
Methods 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
3.1. Ethics and Medical Screening 
 
3.1.1. Study Eligibility Screening 
 
Ethical approval was obtained from the West Virginia University ethics committee 
(IRB# H-22147). All subjects received verbal and written explanation of the 
procedures involved and signed consent forms.  
 
Preliminary screening to determine study eligibility of the subjects was 
accomplished by completing a medical health questionnaire, which ascertained 
any past history of CV conditions and any other medical conditions that may 
conflict with testing. A twelve-lead electrocardiography (ECG) (Nihon Kohden 
Cardiofax GEM) was performed in a sitting position to rule out any cardiac 
abnormalities that would prevent exercise capability. Medical exclusion criteria 
for entry into the studies included those diagnosed as having CAD (angiography, 
stress testing, and other physician determined means), diabetes mellitus, 
myocardial infarction, or stroke. Individuals were selected from a large pool of 
people that responded to local advertisements asking for volunteers.  
 
3.1.2. Risk Factor Assessment 
 
 
Waist Circumference, in centimeters (cm), was measured at the level of the 
umbilicus using a tape measure. Resting BP levels were taken as the average of 
two or three measurements, recorded at least 2 minutes apart, in the right arm 
with an automated pressure monitor (Omron Healthcare Inc.). Participants rested 
for at least 15 minutes before BP was measured. Weight was measured by a 
mechanical balance (Detecto®), height by a stadiometer (Detecto®), and BMI 
was calculated in units of kg/m2. Body fat percentage was obtained through the 
assessment of skinfold thickness, measured at 7 sights (triceps, pectoral, 
subscapula, midaxilla, abdomen, suprailiac, quadriceps) on the body. The 
measurements were then entered into a formula (ExRX.net Body Composition 
Calculator), converting the values into an estimate of each individual’s percent of 
body fat, according to a person’s age and gender. Blood samples were obtained 
after an overnight fast. Blood plasma glucose, HDL cholesterol, and triglycerides 
were analyzed at the hospital Clinical Medicine Laboratory, enzymatically using 
standard procedures. 
 
3.2. Experimental Design  
 
 
The purpose of this study was to examine the impact of 8 weeks of aerobic 
exercise training on arterial stiffness and wall thickness in individuals with the 
MetS. The interventional study design includes 2 groups; the first consisting of 
MetS individuals preforming exercise and a group of MetS individuals who 
maintained their normal lifestyle. The presence of the MetS is defined according 
to the NCEP ATP III definition [17]. Each subject underwent two evaluation 
sessions, before and after the 8-week intervention. Participants reported to the 
laboratory after an overnight fast, abstaining from medications, caffeine, and 
vitamins the morning of the tests. All study sessions were performed with the 
subject supine, and took place between 7:00 and 10:00 AM to avoid circadian 
rhythm bias. Applanation tonometry of the radial artery was performed, producing 
the cPP waveform and central pressure measurements [122]. Wave reflection, 
an integral part of the waveform, was assessed through AIx. Arterial stiffness 
was assessed as PWV using the Sphygmocor (AtCor Medical Pty. Ltd., Sydney, 
Australia). Carotid IMT, used to evaluate arterial remodeling, was measured from 
the images derived from an ultrasound machine (GE Vividi). Finally, FMD, a 
noninvasive measurement, was employed to observed endothelial function [31]. 
3.3. Subjects 
 
 
3.3.1. Metabolic Syndrome Individuals 
 
 
Twenty-one individuals (9 men and 12 women, average age 47 ± 3 years) with 
the MetS were included in this study. Participants were split into to either the 
aerobic exercise training group (n=11) or a sedentary group (n=8), which 
maintained their normal lifestyle and activity level during the duration of the 
study. Two participants did not complete the exercise training protocol, and were 
therefore included only in the cross-sectional analysis. MetS was defined 
according to the NCEP ATP III [17], by the presence of 3 or more of the following 
traits:         
• Abdominal obesity (>102 cm in men and >88 cm in women) 
• Low HDL cholesterol (<40 mg/dL in men and <50 mg/dL in women) 
• Hypertriglyceridemia (>150 mg/dL) 
• Hyperglycemia (>100 mg/dL) 
• High blood pressure (>130/85 mm Hg) or hypertensive medications 
 
3.3.2. Healthy Control Individuals 
 
 
Fifteen healthy, control subjects (6 men and 9 women, aged 41 ± 3 years) were 
enrolled in the study. None were diagnosed with CVD, hypertension, or 
abdominal obesity. 
 
All potential subjects were excluded if they suffered from diabetes mellitus, 
chronic pulmonary disease, symptoms of unstable angina, aortic stenosis, 
anemia, cancer requiring treatment within the last 2 months, or orthopedic or 
neurologic disability that would limit the ability to exercise. Individuals who have 
had a myocardial infarction, stroke, or coronary revascularization were also 
excluded. Subjects who participated in regular exercise (running, cycling, 
swimming, weight lifting, etc.) defined as greater than 30 minutes at least 3 times 
a week were excluded.  
3.4. Experimental Procedures and Training Protocol 
 
 
Exercise training was performed over an 8-week period with subjects visiting the 
on-site gym, the Human Performance Laboratory. Each session consisted of 60 
minutes of aerobic exercise training, 30 minutes on a treadmill and 30 minutes on 
a bicycle. Initially, subjects exercised at 60% of their individually determined 
heart rate (HR) reserve, obtained during the measurement of peak aerobic 
capacity (VO2peak). Every two weeks the exercise intensity increased from 60% 
to 70%, 80%, and finally 85% of their HR reserve. Adherence to the exercise 
prescription was documented through the use of Polar HR monitors and physical 
activity logs. All measurements were performed at least 48 hours following the 
last training session. Across the exercise-training period, there was 90% 
adherence to the training sessions. Subjects not participating in the training were 
instructed to maintain their normal daily lifestyle and activity level.  
 
Participants performed an incremental exercise stress test on a cycle ergometer, 
using the Bruce protocol to obtain maximal HR. The ergometer was placed at a 
45-degree angle for acquisition of arterial and cardiac parameters during the 
stress test. Expired gases were collected using a one-way valve and analyzed 
using a metabolic cart (ParvoMedics TrueOne 2400). VO2peak was defined as 
the highest recorded value during the test. This is in contrast to maximal oxygen 
uptake, which occurs when oxygen consumption plateaus and exercise 
continues, even though the maximum is achieved. HR was recorded halfway 
through each 3-minute stage and at the end of each stage using 12-lead ECG. 
BP was measured by an investigator using a manual sphygmomanometer at 
rest, during each minute and a half stage, and at maximal exercise. Exercise was 
stopped for any of the following reasons: a 20 rating of perceived exertion, if the 
participant achieved age-predicted maximal HR, or if the individual was too 
fatigued to maintain a cadence of 50 revolutions per minute.  
 
 
 
 
 
3.5. Experimental Measures 
 
 
3.5.1. Pulse Wave Analysis 
 
 
Patients were supine with the right arm extended, at heart level, and immobilized 
with foam supports at an angle of 90° from the torso. After an initial rest period of 
10 minutes, applanation tonometry was performed by placing a handheld 
tonometer (strain gauge pressure sensor (AtCor Medical Pty Ltd, Sydney, 
Australia)) over the radial artery, applying pressure to flatten the artery (figure 
3.1). Tonometry requires that the artery to be flattened against a hard surface 
(bone) [122]. Ten completely consistent radial waveforms are then recorded and 
ensembled into a single waveform (figure 3.2). The radial artery pressure is then 
recorded digitally and a generalized transfer function, approved by the food and 
drug administration [24], is used to calculate central pressure indices and 
produce the central waveform (figure 3.2). The SBP and DBP in the radial artery 
were calibrated after entering BP values obtained from the brachial pressure, 
using an automated cuff (Omron Healthcare Inc.) prior to data acquisition. 
Central SBP, DBP, and PP are all measured from the peak and trough data 
obtained from the waveform (Figure 3.3).  
 
  
 
 
 
Figure 3.1. Measurement of 
AIx, PWV, central PP, and BPs 
with applanation tonometry. 
 
This figure illustrates the use 
of a handheld tonometer by 
placing it over the radial artery. 
A radial waveform is produced 
and a generalized transfer 
function is used to calculate 
central pressure indices and 
produce the central waveform. 
Figure 3.2. Radial artery applanation tonometry recording. 
The upper long panel shows the radial pressure waveform above the derived 
central pressure waveform. The bottom left panel demonstrates a magnified radial 
arterial waveform. The bottom right panel provides a magnified derived central 
pressure waveform. Both lower panels show SBP, DP, MAP, and PP. 
 AIx was determined from applanation tonometry of the right radial artery with the 
SphygmoCor system (AtCor Medical Pty Ltd, Sydney, Australia) [122], using the 
central pressure waveform (figure 3.3.A). AIx is the ratio between AP (additional 
pressure added to the forward wave by the reflected wave) to the central PP and 
is expressed as a percentage [24]. For between-group comparison, AIx was 
normalized to a HR of 75 beats per minute (bpm). All measurements were 
subjected to quality control by the software and only high-quality recordings, 
defined as an operator index 80% were included. The MetS group had an 
average index of 90 ± 3, compared to 95 ± 2 for the controls. 
 
3.5.2. Pulse Wave Velocity 
 
 
PWVcf was measured by applanation tonometry, using the Sphygmocor AtCor 
Medical Pty. Ltd., Sydney, Australia [123]. The SBP and DBP in the peripheral 
and central arteries were calibrated after entering BP values obtained from the 
brachial pressure, using an automated cuff  (Omron Healthcare Inc.), prior to 
data acquisition. ECG-gated carotid and femoral artery waveforms were 
sequentially recorded as described early in the radial artery. Aortic length (L) was 
calculated as the difference in the distances (in meters (m)) from the carotid 
sampling site to the suprasternal notch and from the suprasternal notch to the 
femoral artery. The time delay (t, seconds) between the onset of carotid and 
femoral waveforms (foot-to-foot) was determined from the onset of the waveform 
and the R wave, recorded on the ECG during the cardiac cycles (figure 3.3.B). 
PWV was calculated as the ratio of distance to time (PWV = L/t (m/s). The 
PWVcr was measured using the same tonometry technique. The length was 
calculated as the difference in distances from the carotid sampling site to the 
suprasternal notch and from the suprasternal notch to the radial artery. To 
establish the day-to-day reproducibility of PWV measurements in our laboratory, 
we performed a study on 7 subjects of varying age for 3 consecutive testing 
days. The coefficients of variation were 9.0% and 4.3% for PWVcf and PWVcr, 
respectively. 
 
 
        
 
 
 
 
 
 
 
Figure 3.3. Central waveform and ECG-gated carotid and femoral artery waveforms 
	  	  
(A) SBP & DP are the peak and trough of the waveform. AP is the additional 
pressure added to the forward wave by the reflected wave. AIx is the ratio between 
AP and cPP. The reflected wave in this central pressure waveform results in 
augmentation of systolic flow. (B) Aortic length (L) was calculated as the difference 
in the distances (in meters (m)) from the carotid site to suprasternal notch and from 
the suprasternal notch to the femoral artery. The time delay (t, seconds) between the 
onset of carotid and femoral waveforms (foot-to-foot) was determined from the onset 
of the waveform and the R wave, recorded on the ECG during the cardiac cycles 
(Figure 3.4). PWV was calculated as a ratio of distance to time (PWV = L/t (m/s). 
 
A B 
3.5.3      Intima-Media Thickness 
 
Carotid artery IMT was measured from the images derived from an ultrasound 
machine (GE vividi) equipped with a high-resolution linear array transducer. All 
subjects were in a supine position with a slight hyperextension and rotation of the 
neck in the direction opposite the probe. Longitudinal two-dimensional ultrasound 
images of the right common carotid artery were obtained by placing the probe in 
the anterior position of the neck, at approximately 1-2 cm proximal to the carotid 
bifurcation (figure 3.4). The images were recorded for approximately 45 seconds 
and stored for later off-line analysis.  
 
IMT is defined as the distance between the leading edges of the lumen-intima 
and media-adventitia interface [124]. Images of the anterior IMT were measured, 
1 cm proximal to the bifurcation (figure 3.5), during diastole, using the ECG as a 
reference point (end-diastolic phase is between the P and Q wave) (figure 3.5). 
Every third cardiac cycle was recorded for a total of 6 measurements and the 
average was computed to produce the IMT value. A single reader who was 
blinded to the clinical characteristics of the patients did all offline measurements. 
 
  
 
3.5.4. Flow Mediated Dilation 
 
 
Patients rested supine with the right arm extended and immobilized with foam 
supports at an angle of 90° from the torso. HR was continuously monitored with a 
3-lead ECG. A rapid inflation and deflation pneumatic cuff was positioned on the 
imaged arm immediately distal to the antecubital fossa to provide a stimulus to 
forearm ischemia (figure 3.6). A 10-MHz multifrequency linear array probe, 
attached to a high-resolution ultrasound machine (GE Vividi), was used to image 
Figure 3.5. IMT measurement. 
 
Images of the anterior IMT 
were measured, 1 cm proximal 
to the bifurcation during 
diastole. Every third cardiac 
cycle was recorded for a total 
of 6 measurements and the 
average was computed to 
produce the IMT value.	  
Figure 3.4. Ultrasound probe 
recording carotid IMT. 
 
Longitudinal two-dimensional 
ultrasound images of the right 
common carotid artery were 
obtained, by placing the probe 
in the anterior position of the 
neck, at approximately 1-2 cm 
proximal to the carotid 
bifurcation. 
	  
the brachial artery in the distal third of the upper arm. Duplex ultrasound was 
used for simultaneous acquisition of B-mode diameter and Doppler velocity 
signals, to use for offline assessment of change in diameter and flow velocity, 
respectively [125]. The probe was held stable in a stereotactic clamp (figure 3.6). 
After baseline images were obtained, the cuff was inflated to 250 mmHg for 5 
minutes. Following limb ischemia there is a rapid increase in forearm blood flow, 
which slowly returns to baseline values, and is termed reactive hyperemia [125]. 
Digitized images of the right brachial artery (figure 3.7) were captured 
continuously for 30 seconds before cuff inflation and for 5 minutes following cuff 
release, to document the endothelial-dependent vasodilator response. 
  
The arterial diameter was measured from the recordings captured during the 
FMD response (figure 3.7). Measurements were acquired from visual inspection 
by placing ultrasonic calipers from the anterior to the posterior wall. For the 
reactive hyperemia scan, diameter measurements were taken every 3rd cardiac 
cycle for the entire recorded duration; and the measurements were averaged. 
Arterial diameters in scans after reactive hyperemia were expressed as 
percentages of the first control scan [((peak diameter – average resting diameter) 
/ average resting diameter) x 100%]. Flow was calculated from Doppler velocity 
and artery diameter. Reactive hyperemia was calculated as the maximum flow 
recorded after cuff deflation divided by the flow during the resting baseline 
[((peak velocity – average resting velocity) / average resting velocity) x 100%]. 
The mean artery diameter and percent dilatation were obtained by averaging the 
measurements taken over all occasions on which that patient was studied.  
 
 
 
 
 
Figure 3.6. FMD technique used 
to assess endothelial-dependent 
vasodilation. 
 
Patients rested with the right arm 
extended and immobilized with 
foam supports at an angle of 90° 
from the torso. A pneumatic cuff 
was positioned on the arm distal 
to the antecubital fossa to provide 
a stimulus to forearm ischemia.	  
 
Figure 3.7. Recordings and measurement of the right brachial artery during FMD. 
Digitized images of the brachial artery, captured continuously for 30 seconds before 
cuff inflation and for 5 minutes beginning 30 seconds before cuff deflation to 
document the endothelial-dependent vasodilator response. The arterial diameter 
was measured from the recordings captured during the FMD response. 
Measurements were taken from the anterior to the posterior wall every 3rd cardiac 
cycle for the entire recorded duration and averaged. 	  
	  
Percent change in FMD was normalized to shear rate area under the curve 
(FMD:SRAUC) to control for the presence of the large inter-subject variability in 
reactive hyperemia-induced shear stress. Shear rate (an estimate of shear 
stress) was calculated as 4 x mean blood velocity/arterial diameter [125]. Pike et 
al [126] concluded that the SRAUC, not peak shear, as the critical determinant of 
the FMD response, and should be used for normalization. Peak shear rate 
represents only the portion of FMD response immediately following cuff release, 
where as SRAUC represents the shear stimuli responsible for the entire duration of 
post-cuff release, up till the peak diameter change; calculated for each individual. 
 
3.6. Metabolic Risk Score 
 
 
The relationships between the Metabolic Risk Score (MRS) and select baseline 
aspects of metabolic and hemodynamic parameters, and arterial function were 
also investigated. It was not originally an aim of our study to look at the effect of 
the MRS on arterial stiffness or remodeling. However, after observing significant 
improvement in several measurements, and other changes that just failed to 
reach significance, we felt is was important to observe participants who were 
very close to being classified as either having the MetS or a healthy control, on a 
continuous risk score. Eight additional participants, who presented with only 2 out 
of the 5 criteria for MetS were included in the MRS regression analysis (n=44). 
The diagnostic score was created by a group, Macchia et al [127], who exploited 
the individual diagnostic components of the MetS aimed at predicting the risk of 
late-onset diabetes to be easily used in clinical practice. They assigned points to 
each risk factor (table 3.1), which were weighted proportionally to the value of the 
B-coefficients of multivariate analysis (including metabolic parameters that were 
categorized as statistical quintiles, relative to time-to-diabetic event). The MRS is 
then obtained by summing all the individual points. 
Table 3.1. Metabolic risk factors and risk point valuation. 
 
 
Criteria Risk Points 
Men 
 
       3 
Age >50 years 
 
       4 
Hypertension (systolic >135 mmHg,  
Diastolic >85 mmHg 
       2 
BMI (kg x m-2) 
   <26 
   26-27 
   ≥28 
 
       0 
       3 
       6 
 
Triglycerides (mg/dl) 
   <100 
   100-159 
   160-199 
  ≥200 
 
        
       0 
       5 
       7 
       9 
 
HDL Cholesterol (mg/dl) 
   ≥50 
   30-49 
   <30 
 
 
       0 
       3 
       5 
 
Fasting Glucose (mg/dl) 
   <80 
   80-99 
   90-99 
   100-109 
   ≥110 
 
 
 
       0 
       5 
      10 
      16 
      28 
 
3.7. Statistics 
 
 
All data are presented as Means ± SEM. Data from each experiment were first 
tested for normality (Kolmogorov-Smirnov test). Normally distributed data were 
analyzed for statistically significant differences using parametric tests. Simple 
comparisons between two independent cases were analyzed using Student’s 
two-tailed independent t-test. Comparisons between the same data sets were 
analyzed using Paired Sample t-test. More complex comparisons were 
conducted using repeated measures analysis of variance followed by Turkey’s 
HSD post-hoc analysis. 
 
Linear regression analyses were performed to determine the association among 
variables. In all cases, MRS was used as the predictor variable. Pearson 
product-moment correlation coefficients were used to indicate the magnitude and 
direction of relations among variables. The slopes of the regression lines 
(comparing MRSs and the dependent variable) were compared using analysis of 
covariance, which included an interaction term.  
 
In general, all analyses were performed with SPSS Statistics 20 (SPSS Inc, 
Chicago, IL, U.S.A.). P-values <0.05 were considered statistically significant. 
	  	  
	  
 
 
 
Chapter 4 
 
 
 
 
Results 
 
 
 
 
 
 
 
 
 
 
 
4.1. Baseline Characteristics of Study Population 
 
 
Comparisons of baseline characteristics between MetS individuals (n=21) and 
healthy controls (n=15) are displayed in table 4.1. The MetS participants were not 
significantly different in age than controls. Our data also showed that there is no 
significant difference in height (171 ± 2 vs. 169 ± 2 cm) or HR, where the MetS 
group averaged 69 ± 2 bpm compared to 73 ± 4 bpm for the controls.  
MetS individuals weighed significantly (p<0.001) more (236 ± 9 vs. 153 ± 8 
pounds; p<0.001), had a higher BMI (36.8 ± 1.3 vs. 24.3 ± 1.1 kg x m-2; p<0.001) 
and body fat % (35.1 ± 1.3 vs. 23.3 ± 1.7 %, p<0.001) relative to the healthy 
controls. 
All of the criteria for the MetS defined by the NCEP ATP III [55], were significantly 
different in the two groups, except for HDL cholesterol. Although not significant 
HDL cholesterol was lower in the MetS individuals (43.4 ± 3.5 mg/dl) compared 
to healthy controls (52.0 ± 3.6 mg/dl). This shows that the study population was a 
true representation of the MetS. Within the group of individuals with the MetS, 
62% had hypertension, 86% had abdominal obesity, 43% had elevated 
triglyceride levels, 71% had low HDL cholesterol concentration, and 53% had 
high fasting plasma glucose. 
 
 
 
Table 4.1. Clinical characteristics of 21 MetS individuals and 15 healthy controls 
Variables Metabolic 
Syndrome 
(n=21) 
Controls (n=15) P Value 
Age (years) 47 ± 3 41 ± 3 0.14 
Men (%) 43% 40% - 
Height (cm) 171 ± 2 169 ± 2 0.468 
Weight (pounds) 236 ± 9 153 ± 7 <0.001 
Body Mass Index (kg x m-2) 36.8 ± 1.3 24.3 ± 1.1 <0.001 
Body Fat (%) 35.1 ± 1.3 23.3 ± 1.7 <0.001 
Waist (cm) 116 ± 3 83 ± 3 <0.001 
Triglycerides (mg/dl) 163 ± 15 92 ± 12 0.001 
HDL Cholesterol (mg/dl) 43.4 ± 3.5 52.0 ± 3.6 0.104 
Serum Glucose (mg/dl) 100 ± 2 95 ± 2 0.040 
Heart Rate (beats/min.) 67 ± 2 73 ± 4 0.311 
Brachial SBP (mm Hg) 133 ± 3 115 ± 3 <0.001 
Brachial DBP (mm Hg) 83 ± 2.0 73 ± 2 0.001 
Brachial MAP (mm Hg) 102 ± 2 89 ± 2 <0.001 
Brachial PP (mm Hg) 49 ± 3 47 ± 4 0.639 
Central SBP (mm Hg) 123 ± 3 104 ± 2 <0.001 
Central DBP (mm Hg) 85 ± 2 83 ± 5 0.600 
Central PP (mm Hg) 38 ± 3 29 ± 1 0.018 
 
Data are expressed as mean ± SEM for n = 36. Significant difference between 
MetS individuals and controls at p<0.05. 
The MetS group had significantly (p<0.001) higher PWVcf (8.0 ± 0.3 m/s) than 
the control group (6.4 ± 0.3 m/s) (figure 4.1A). The PWVcr (figure 4.1B) was not 
significantly (p=0.61) different between the MetS individuals (8.0 ± 0.3 m/s) and 
control group (7.9 ± 0.2 m/s). After adjusting for MAP, PWV remained 
significantly (p<0.001) elevated in the MetS compared to controls.  
An interesting finding was the baseline characteristic detailing the concept of 
pressure amplification and differences of stiffness in different arterial segments. 
The MetS group had a significantly (p<0.05) higher cPP (figure 4.2A) of 38.2 ± 
3.5 mmHg compared to the control group (28.8 ± 1.4 mmHg). However, the 
brachial PP (bPP) (figure 4.2B) was not significantly different between the MetS 
individuals (48.9 ± 3.0 mmHg) and control group (46.5 ± 4.1 mmHg).  
In addition to PWV and cPP measures of arterial stiffness, The MetS group had 
significantly (p<0.05) higher carotid IMTmax (0.72 ± 0.04 mm) than the control 
group (0.61 ± 0.02 mm) (figure 4.3A). The carotid IMTavg (figure 4.3B) was also 
higher in the MetS group (0.60 ± 0.03 vs. 0.53 ± 0.02 mm), although it fell slightly 
short of reaching significance (p=0.057).  
 
 
 
 Figure 4.1. Mean comparison of carotid-femoral (A) and carotid-radial (B) PWV 
between controls and MetS. Data are expressed as mean ± SEM. Significant 
difference between the two at *p<0.001. 
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 Figure 4.2. Mean comparison of cPP (A) and bPP (B) between controls and 
MetS. Data are expressed as mean ± SEM. Significant difference between the 
two at *p<0.05. 
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Figure 4.3. Mean comparison of maximum (A) and average (B) IMT between 
controls and MetS. Data are expressed as mean ± SEM. Significant difference 
between the two at *p<0.05. 
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Our data showed that the MetS group had a differential impact on wave reflection 
(figure 4.4A) of 23.8 ± 2.9% compared to 18.3 ± 4.2% for the controls, although 
significance was not established. When corrected for HR, the AIx@75 (figure 
4.4B) was not different in the MetS group (18.4 ± 2.7%) compared to the control 
group (12.8 ± 4.1%), while significance again was not reached. 
 
 
Figure 4.4. Mean comparison of AIx (A) and AIx@75 (B) between controls and 
MetS. Data are expressed as mean ± SEM. p=0.27 and p=0.25, respectively. 
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In addition to arterial function changes, peak aerobic capacity, measured as 
VO2peak (figure 4.5) was also significantly (p<0.01) lower in the MetS group 
(17.1 ± 1.1 ml/kg/min) than the control group (23.3 ± 1.6 ml/kg/min). 
 
Figure 4.5. Mean comparison of VO2peak between controls and MetS. Data are 
expressed as mean ± SEM. Significant difference between the two at p<0.01. 
 
Our data showed no significant difference in measures of endothelial function 
between the MetS group and healthy controls. The MetS group had 7.4 ± 0.9 % 
change in FMDdia (figure 4.6A) compared to healthy controls that had a 7.8  ± 
1.5 % change. The MetS individuals had a FMDflow % change (figure 4.6B) of 
1452 ± 167% and the controls a 1887 ± 263 % change. Finally, when normalized 
for SRAUC (figure 4.6C) the FMDdia % change between the MetS and healthy 
control group remained insignificant (1.8 x 10-4 ± 2.5 x 10-5 vs. 2.3 x 10-4 ± 4.1 x 
10-5 % change).  
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 Figure 4.6. Mean comparison of FMDdia % change (A), FMDflow % change (B), 
and FMD:SRAUC (C) between controls and MetS. Data are expressed as mean ± 
SEM. p=0.80, p=0.15, and p=0.25, respectively. 
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4.2. Effects of Aerobic Exercise on Measures of Arterial 
Stiffness 
 
 
Of the 21 Mets individuals, 11 underwent 8 weeks of aerobic exercise training for 
a period of one-hour, 3 times a week. Eight other Mets individuals maintained 
their normal daily lifestyle and performed no physical activity during this period of 
time. The two remaining MetS individuals included in the baseline analysis did 
not complete the exercise protocol and follow-up testing.  
There were no significant differences at baseline (table 4.2) between the MetS 
individuals who performed exercise and the sedentary group of MetS participants 
in every aspect of metabolic, hemodynamic, and anthropometric measurement; 
except for HDL cholesterol which was higher in the trained group (50.9 ± 5.5 
mg/dl) compared to non-trained participants (47.4 ± 4.3), reaching significance 
(p<0.05).  
There was no significant baseline difference of carotid-femoral or carotid-radial 
PWV between the MetS trained and non-trained group. The exercise-trained 
group (figure 4.7A) had a significant (p<0.05) decrease in PWVcf (8.1 ± 0.5 vs. 
7.2 ± 0.4 m/s), while the non-trained group experienced no significant change 
(8.0 ± 0.5 vs. 7.8 ± 0.3 m/s). The PWVcr (figure 4.7B) did not change significantly 
for either the trained group (7.9 ± 0.4 vs. 8.0 ± 0.3 m/s) or the non-trained 
individuals (8.1 ± 0.1 vs. 7.7  ± 0.3 m/s). 
 
Table 4.2. Baseline clinical characteristics of 11 MetS trained individuals and 8 
MetS non-trained Individuals before and after exercise training or non-training. 
Variables 
MetS Trained (n=11) 
    Before           After 
MetS Non-Trained 
(n=8) 
    Before            After 
Compared 
before 
exercise 
Compared 
after 
exercise 
Age (years) 46 ± 4 - 47 ± 3 - 0.723 0.723 
Men (%) 27% - 50% - 0.993 0.982 
Height (cm) 168 ± 3 - 174 ± 2 - 0138 0.138 
Weight (pounds) 239 ± 9 238 ± 11 239 ± 8 238 ± 13 0.589 0.415 
Body Mass Index              
(kg x m-2) 38.7 ± 1.8 38.6 ± 1.8 35.8 ± 1.5 35.6 ± 1.6 0.274 0.765 
Body Fat (%) 36.6 ± 1.4 36.4 ± 1.4 33.4 ± 2.6 34.1 ± 2.9 0.286 0.837 
Waist (cm) 118 ± 4 118 ± 4 113 ± 3 113 ± 3 0.194 0.121 
Triglycerides (mg/dl) 137 ± 18 175 ± 24 175 ± 24 161 ± 28 0.620 0.111 
HDL Cholesterol (mg/dl) 50.9 ± 5.5 47.4 ± 4.3 47.4 ± 4.3 33.0 ± 4.9 <0.05 0.992 
Serum Glucose (mg/dl) 99 ± 2 97 ± 2 97 ± 3 85 ± 12 0.307 0.281 
Heart Rate (beats/min.) 65 ± 3 63 ± 3 63 ± 3 67 ± 4 0.292 0.669 
Brachial SBP (mm Hg) 129 ± 5 126 ± 4 126 ± 4 124 ± 2 0.776 0.120 
Brachial DBP (mm Hg) 80 ± 3 82 ± 3 82 ± 3 81 ± 2 0.440 0.109 
Brachial MAP (mm Hg) 98 ± 2 97 ± 3 97 ± 3 101 ± 6 0.354 0.991 
Brachial PP (mm Hg) 49 ± 3 44 ± 2 47 ± 4 43 ± 2 0.970 0.612 
Central SBP (mm Hg) 119 ± 4 116 ± 4 116 ± 4 112 ± 3 0.877 0.135 
Central DBP (mm Hg) 82 ± 2 81 ± 3 81 ± 3 82 ± 2 0.451 0.321 
Central PP (mm Hg) 37 ± 6 34 ± 3 34 ± 3 31 ± 2 0.582 0.936 
Data are expressed as mean ± SEM. P values represent differences in means at 
baseline, significance between trained and non-trained Individuals at p<0.05. 
	  Figure 4.7. Mean comparison of carotid-femoral (A) and carotid-radial (B) PWV in 
MetS trained vs. non-trained individuals before and after 8 weeks of aerobic 
exercise training. Data are expressed as mean ± SEM. Significant difference 
before and after the 8-week intervention, *p<0.05, within each group. 
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There was no significant baseline difference between IMTavg or IMTmax 
between the MetS trained and non-trained group. The exercise-trained group 
(figure 4.8A) witnessed no significant change in IMTavg (0.58 ± 0.03 vs. 0.58 ± 
0.03 mm), and the non-trained group also had no significant change (0.59 ± 0.05 
vs. 0.61 ± 0.05 mm). IMTmax (figure 4.8B) did not change significantly for the 
trained group (0.69 ± 0.04 vs. 0.69 ± 0.03 mm) or the non-trained individuals 
(0.71 ± 0.08 vs. 0.71  ± 0.05 mm). 
There was no significant baseline difference in cPP between the MetS trained 
and non-trained group. Following 8-weeks of aerobic exercise training cPP 
(figure 4.9A) in the trained group decreased (37.4 ± 6.0 vs. 33.5 ± 2.7 mmHg), 
although not significantly. The non-trained group also had a decrease in cPP 
(34.3 ± 1.7 vs. 30.8 ± 1.7 mmHg), which was also found not to be significant.  
AIx was analyzed with PWA to observe the effect of aerobic exercise train on 
wave reflections. After normalizing AIx to heart rate of 75, there was no 
significant difference in AIx@75 (figure 4.9B) at baseline between the Mets 
trained group (18.2 ± 3.5 %) and non-trained individuals (14.0 ± 5.0 %). 
Following the 8 weeks of exercise the trained group decreased their AIx@75 to 
14.6 ± 4.7 %, which just fell short of reaching significance (p=0.075). The non-
trained group had no significant change in AIx@75 (14.0 ± 5.0 vs. 13.5 ± 4.3 %).  
 
Figure 4.8. Mean comparison of average (A) and maximum (B) carotid IMT in 
MetS trained vs. non-trained individuals before and after 8 weeks of aerobic 
exercise training. Data are expressed as mean ± SEM.  
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Figure 4.9. Mean comparison of central PP (A) and AIx@75 (B) in MetS trained 
vs. non-trained individuals before and after 8 weeks of aerobic exercise training. 
Data are expressed as mean ± SEM.  
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Endothelial function was analyzed to observe the functional contribution of 
effects of aerobic exercise on arterial stiffness. The % change in FMDflow (figure 
4.10A) was not significantly different between the trained (1579 ± 282 % change) 
and non-trained group (1298 ± 200 % change).  Following 8 weeks of exercise, 
the trained group had a slight decrease in FMDflow (1437 ± 258 % change), but 
not significant. The non-trained group saw no significant change in % FMDflow 
(1298 ± 200 vs. 1303 ± 175 % change). The % change in FMDpdia (figure 4.10B) 
was not significantly different at baseline in the non-trained MetS group (9.2  ± 
1.7 %) compared to the trained group (6.6 ± 1.0 %).  Following the 8 weeks of 
aerobic training, the trained group increased FMDpdia % change from 6.6 ± 1.0 
to 8.1 ± .59 %, but not significantly. The non-trained group also had an increase, 
not significant, in FMDpdia % change (9.2 ± 1.7 vs. 12.0 ± 2.7 % change). When 
normalized to shear rate (figure 4.10C) there was no significant difference at 
baseline between the trained and non-trained groups (1.6 x 10-4 ± 4.0 x 10-5 vs. 
2.0 x 10-4 ± 1.9 x 10-5). The non-trained group had no change after the 8 weeks 
(1.9 x 10-4 ± 7.1 x 10-5), while the trained group had an increase (1.6 x 10-4 ± 4.0 
x 10-5 vs. 2.2 x 10-4 ± 3.3 x 10-5), although not significant. 
There was no significant difference in VO2peak (figure 4.11) at baseline, but was 
slightly higher in the non-trained group (19.0 ± 1.9 ml/kg/min) before the exercise 
intervention, compared to the trained group (16.0 ± 1.4 ml/kg/min). Following 8-
weeks of exercising the trained group had a significant (p=0.05) increase in peak 
aerobic capacity from 16.0 ± 1.9 to 18.2 ± 1.7 ml/kg/min. The non-trained group 
had no change in VO2peak (19.0 ± 1.9 vs. 18.7 ± 1.3 ml/kg/min). 
 Figure 4.10. Mean comparison of FMDflow % change (A), FMDpdia % change 
(B), and FMD:SRAUC (C) in MetS trained vs. non-trained individuals before and 
after 8 weeks of aerobic exercise training. Data are expressed as mean ± SEM.  
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Figure 4.11. Mean comparison of VO2peak in MetS trained vs. non-trained 
individuals before and after 8 weeks of aerobic exercise training. Data are 
expressed as mean ± SEM. Significant difference before and after the 8-week 
intervention, *p=0.05, within each group. 
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4.3. Arterial Stiffness and Metabolic Risk Score 
The relationships between the MRS and select baseline aspects of arterial 
dysfunction were also investigated. Eight additional participants, who presented 
with only 2 out of the 5 criteria for the MetS were included in the MRS regression 
analysis for an n=44. MRS and age were not correlated; therefore no statistical 
correction was performed.  
Table 4.3 outlines the direct comparisons of the MRS to the MetS inclusion 
criteria. All indices were found to be significantly correlated with the MRS and 
evenly distributed, except for a lower negative correlation between the risk score 
and HDL cholesterol.  
 
Table 4.3 Direct comparisons of the correlation coefficients for the MRS to all the 
MetS inclusion criteria. 
 Waist Triglycerides HDL 
Cholesterol 
Glucose SBP 
MRS 
R value 
0.61** 0.62** -0.37* 0.66** 0.68** 
 
Significant Pearson’s correlations at *p<0.05, **p<0.001 
 
 
Initially, relationships of arterial stiffness assessments, with all participants 
combined, were investigated. The results revealed a significantly (p<0.01) 
positive correlation (r=.42) of PWVcf to the MRS (figure 4.12A). Assessment of 
PWVcr (figure 4.12B) revealed no significant correlation with the MRS.  
After assessment of arterial thickness; both average and maximum carotid IMT 
(figure 4.13) were found to be positively correlated (r=.38 and r=.35, respectively) 
to the MRS; both measures reached significance (p<0.05).  
Finally, cPP and AIx, adjusted for a heart rate of 75, were also assessed against 
the MRS. cPP and the MRS (figure 4.14A) were found to be positively correlated 
(r=.47, p<0.001), but AIx@75 had no significant correlation to the MRS (figure 
4.14B).  
 
 
	  
  
Figure 4.12. The relationships of PWVcf to MRS (A) and PWVcr to MRS (B) in 
controls (w), MetS (w), and those with 2 of the 5 MetS components (w).   
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Figure 4.13. The relationships of IMTavg to MRS (A) and IMTmax to MRS (B) in 
controls (w), MetS (w), and those with 2 of the 5 MetS components (w).   
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Figure 4.14. The relationships of cPP to MRS (A) and AIx@75 to MRS (B) in 
controls (w), MetS (w), and those with 2 of the 5 MetS components (w).   
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After investigating the relationships between MRS and measures of arterial 
stiffness, we sought to confirm the relationships between measures of arterial 
stiffness and wall remodeling. First, the results revealed a significantly (p<0.05) 
positive correlation (r=.35) between PWVcf and IMTavg (figure 4.15A). 
Assessment of PWVcf to IMTmax (figure 4.15B) also revealed a positive 
correlation (r=.38, p<0.05). There was a strong correlation (r=.51, p<0.001) of 
cPP to IMTavg (figure 4.16A). A positive correlation (r=.45, p<0.01) was also 
found between cPP and IMTmax (figure 4.16B). 
We looked at the relationship of PWVcf to indices of peripheral and central PPs 
to further study the degeneration of pulse pressure amplification with increased 
stiffening (figure 4.17). PWVcf was strongly correlated (r=.48, p=0.001) to cPP, 
but was found to not be correlated with bPP. 
 
 
 
 
 
 
 
 
 
 
Figure 4.15. The relationships of PWVcf to IMTavg (A), and PWVcf to IMTmax  
 
(B) in controls (w), MetS (w), and those with 2 of the 5 MetS components (w).   
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Figure 4.16. The relationships cPP to IMTavg (A), and cPP to IMTmax (B) in 
 
controls (w), MetS (w), and those with 2 of the 5 MetS components (w).   
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Figure 4.17. The relationships of PWVcf to cPP (A), and PWVcf to bPP (B) in 
controls (w), MetS (w), and those with 2 of the 5 MetS components (w).   
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Our group was also interested in the relation of peak aerobic capacity to the 
MRS. We first discovered a strong negative correlation (r=-.40, p<0.001) of 
VO2peak to the MRS (figure 4.18).  
 
We then looked at the relationship between assessments of arterial stiffness and 
VO2peak. A negative correlation (r=-.40, p<0.01) was found between PWVcf and 
VO2peak (figure 4.19A). A negative correlation (r=-.43, p<0.01) was discovered 
with cPP to VO2peak (figure 4.19B). Finally, IMTavg and VO2peak (figure 4.19C) 
were also negatively correlated (r=-.41, p<0.01). 
 
 
 
Figure 4.18. The relationship of VO2peak correlated to MRS in controls (w), MetS 
(w), and those with 2 of the 5 MetS components (w).   
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Figure 4.19. The relationships of PWVcf to VO2peak (A), cPP to VO2peak (B), 
and IMTavg to VO2peak (C) in controls (w), MetS (w), and those with 2 of the 5 
MetS components (w).   
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Chapter 5 
 
 
 
 
Discussion 
 
 
 
 
 
 
CVD is prevalent in industrialized societies, and metabolic disease is a dominant 
risk factor for morbidity and mortality [7]. Consequently, a primary public health 
concern is to understand the mechanisms by which the MetS is associated with 
CVD, and to establish appropriate prevention and intervention strategies. One 
putative mechanism that has emerged as an important risk factor for CVD is the 
increase in arterial stiffness in the MetS population [128]. This single 
degenerative alteration to the vasculature has profound effects on CV health, 
contributing to systolic hypertension, increased PP, LVH, diastolic dysfunction, 
stroke, atherosclerotic coronary and peripheral disease, congestive heart failure, 
and myocardial infarction [27, 68]. Although arterial stiffness and structural 
remodeling is as a natural consequence of aging, it occurs at an accelerated rate 
in individuals who suffer from the MetS [129, 130].  
The purpose of this study was to examine the impact of a therapeutic 
intervention, of aerobic exercise training, on arterial stiffness and wall remodeling 
in individuals with the MetS, compared to inactive MetS participants. We 
evaluated the effect of aerobic exercise training on carotid IMT, arterial 
remodeling that occurs as a consequence of stiffening. We also observed the 
effect of aerobic exercise on PWV and cPP, both measures of arterial stiffness. 
No previous study had examined the effect of chronic, aerobic exercise on 
measures of stiffness or wall thickness in MetS individuals. The major finding of 
this study was that 8-weeks of aerobic exercise training significantly attenuated 
measures of arterial stiffness in MetS individuals, but did not have an effect on 
carotid IMT. 
5.1. Summary of Study Participant Characteristics 
 
 
Prior to examining the aims of the thesis, it was important to first analyze the 
baseline characteristics of MetS individuals compared to healthy controls. The 
presence of the Mets, defined using the NCEP ATP III [55] definition, was clearly 
demonstrated in the baseline metabolic and hemodynamic characteristics (table 
4.1). The Mets group had triglyceride parameters 75% higher, HDL cholesterol 
16.5% lower, and BP 16% higher than healthy controls. Increased waist 
circumference is considered a key inclusion criterion for the MetS. In fact, 86% of 
our study population met the waist circumference inclusion criteria, and the 
average circumference was 39% higher than those without the syndrome. 
Recently, there has been an increased focus on the accumulation of excess fat in 
the abdominal region, and it has been proposed that waist circumference is a 
better indicator of the risk of developing CVD, than either BMI or the waist-to-hip 
ratio [9]. Also, a pattern of abdominal obesity correlates more strongly with insulin 
resistance, a major risk factor for diabetes, and can cause arterial stiffness by 
disrupting the NO-VSMC pathway, increasing VSMC tone [131]. Further, we 
performed regression analysis comparing the MetS inclusion criteria to the MRS. 
All indices were strongly correlated with the MRS (table 4.3), with even 
distribution, except for lower, negative correlation of HDL cholesterol to the MRS. 
The present study demonstrated that people with the MetS had increased 
stiffening, measured as PWVcf, compared to their healthy counterparts (figure 
4.1). This is in agreement with previous studies showing accelerated arterial 
stiffening in MetS individuals compared to healthy controls [130]. However, the 
MetS was shown to be unrelated to upper limb PWV, measured between the 
carotid and radial sites. The control group on average had a PWVcr of 7.9 m/s 
and the MetS 8.0 m/s. Regression analysis also confirmed that there is no 
relationship in peripheral measures of arterial stiffness to the MRS, but both 
PWVcf (figure 4.12) and cPP (figure 4.14) had a positive correlation to the MRS. 
This confirms previous findings that various arterial segments respond differently 
to arterial remodeling [73]. In a healthy arterial system, the compliance of arteries 
decreases with increasing distance from the heart, and the velocity of the wave 
travels faster in more muscular, peripheral arteries as elastin material declines 
[132]. Central, elastic arteries lose compliance with advancing age and increased 
metabolic risk, whereas compliance in the peripheral arteries change little with 
advancing age and disease states [133, 134]. This results in an inability of the 
central arteries to cushion pulse waves generated from the heart, placing 
increased pressure on the microcirculation and earlier return of the wave, 
increasing LV workload [75]. 
Previous investigations suggest factors such as age, HR, and height are key 
factors that influence central and peripheral pressures, and can therefore 
modulate PWA and PWV [47]. In a stiffened artery, the increased duration of 
ejection period and slowed HR, as a result of LVH, increases the likelihood that 
the reflected wave will return earlier during systole, reducing the boost to 
coronary perfusion [24]. Small statures leads to an earlier return of the wave 
because points of reflection are closer to the aorta. Conversely, with increased 
height the reflection sites are father from the aorta, and the reflected wave 
arrives at a later point, during diastole, reducing the pressure load on the LV and 
increasing myocardial perfusion [24] Therefore, an individual of short stature and 
a higher workload, as a result of a slower HR, could suffer from a higher PWV, 
that is not dependent on mechanical stiffening. In our study there was no 
significant difference in HR, height, or age (table 4.1) between the groups, 
therefore our results are not confounded by these characteristics. 
Individuals with the MetS also had a marginally higher SBP than patients without 
the syndrome, and BP is both a well-known cause and consequence of large 
artery stiffness [135]. At higher BP, the elastic modules of collagen dominate and 
the non-linear nature of elasticity should be underlined: the change in elastic 
modulus for a given change in intra-arterial pressure is greater at high BP than at 
low BP [135]. Thus, BP increases can lead to a significant PWV enhancement. 
This decrease in compliance, with increasing BP, should be distinguished from 
structural changes leading to increased stiffness [47]. This supports the notion 
that the increased stiffness, observed in the MetS population, is not a sole 
consequence of the increase in distending pressures.  
An interesting finding of this study is that the MetS individuals had a cPP 10 
mmHg higher than the healthy controls, with no significant difference in bPP 
(figure 4.2). There are several limitations that exist with peripheral BPs, that can 
be reduced with the accurate measurement of cPP [24]. Historically, DBP had 
been regarded as the primary indicator of CV risk. However, it ignores the 
pulsatile component (PP) of arterial pressure [135]. The disparity between central 
and peripheral PPs are mainly characterized by the differences in arterial 
stiffness and wave reflection [136]. In our population of MetS individuals the 
increased reflections and stiffness were related with increased central pressures 
independently of brachial pressure. McEniery et al [136] confirmed CV risk 
factors such as hypertension, smoking, diabetes, and high cholesterol were all 
associated with more profound increases in central pressures, even after 
adjusting for differences in age, height, and HR. Central pressures are now 
considered to be a more accurate predictor of CV events [137, 138], react 
differently to hypertensive medications [139], and are a better representation of 
pressures in the central arteries because of pressure amplification [136]. 
Recently, Miyashita et al. [139] confirmed that antihypertensive drugs with 
vasodilator properties lower central SBP independently of peripheral BP, 
whereas non-vasodilators may even raise central SBP. 
In a healthy, compliant arterial system, there is a gradual widening of PP moving 
from the central to the peripheral arteries as SBP rises with increasing distance 
from the heart and DBP declines slightly [47]. In a stiffened artery the 
amplification of pressures is attenuated as cPP increases [136]. Indeed, our 
analysis showed a positive correlation of PWVcf to cPP (figure 4.17), but no 
correlation with bPP. This supported past findings, suggesting cPPs are a better 
indicator of arterial dysfunction [140]. McEniery et al [136] found considerable 
inter-individual variability between participants, and by placing individuals in BP 
categories (normal, stage 1 or 2 hypertensive) overlap occurs between aortic 
SBP and BP categories. McEniery’s group found that greater than 70% of 
individuals with high-normal SBP had similar central SBP to those individuals 
with stage 1 hypertension [136]. There was also significant variation in central 
pressure between individuals, despite grouping of similar brachial pressures. 
These are important implications for the categorization of hypertension; if cPP is 
more important in defining an individual’s risk, then categories based on central, 
rather than peripheral pressure may be more useful. 
Our study also found that AIx tended to be 44% higher, when adjusted for HR, in 
the MetS individuals compared to healthy controls (figure 4.4). There is evidence 
that increased arterial stiffness can cause a more rapid return of the reflected 
systolic wave from small peripheral vessels, such that this augments central 
aortic systolic pressure [141]. This would increase cardiac afterload and reduce 
diastolic pressure and coronary perfusion. Although AIx failed to reach 
significance, our data clearly demonstrated elevated arterial stiffness in the Mets 
group, through PWV and cPP. 
Arterial stiffness is influenced by structural components related to the 
architecture and composition of the arterial wall, such as the thickness of the 
intima and media, and the type and content of collagen and elastin in the 
extracellular matrix [96]. As presented earlier, IMT occurs with aging, even in 
populations without incidence of atherosclerosis [81]. A thickened carotid artery 
is relevant in the discussion of stiffening because of the changes that occur in the 
arterial wall composition in a stiffened artery. Increased stiffness contributes to a 
greater rise in cPP, which is a strong determinant of CV events, including CAD 
and stroke [71]. Remodeling of the carotid artery may be a large contributor to 
CVD, and the association of carotid IMT with CAD and stroke may thus involve a 
common mechanical factor, such as cPP. We confirmed that PWVcf was 
positively correlated with both IMTmax and IMTavg (figures 4.15) and that cPP 
was strongly correlated with both measurements of carotid IMT (figure 4.16). 
Boutouyrie et al [71] also found a stronger relation of carotid pulse pressure 
(r=0.42, P<0.001) than brachial pulse pressure (r=0.27, P<0.001) to carotid IMT 
in 167 normotensive and hypertensive volunteers. The rise in central pressures 
observed in the MetS group, could be responsible for some of the carotid 
thickening, in response to the increased fatiguing effect of cyclic stress observed 
in elevated pressures, which results in hyperplasia and hypertrophy of VMSC 
and increased collagen deposition [69].  
Carotid IMT measured at both the average and maximum point were found to be 
higher in the MetS group compared to controls (figure 4.3), although maximum 
IMT barely failed to reach significance. Carotid IMTavg was 0.07 mm higher and 
carotid IMTmax 0.11 mm higher than the control group. The future risk of 
myocardial infarction increases by 15%, and stroke risk by 18%, with an increase 
of 0.1 mm in carotid IMT [56]. We also confirmed that both IMTavg and IMTmax 
were positively correlated with higher metabolic risk (figure 4.13). 
Dynamic factors are mainly related to VSMCs and regulated by paracrine, 
endocrine, and neural mechanisms, including endothelium derived compounds 
[141]. Endothelium-derived compounds, such as NO, endothelium-derived 
hyperpolarizing factors, prostaglandins, and endothelins, play a major role in the 
dynamic regulation of arterial tone, and appear to modulate the state of arterial 
stiffness [141]. Several lines of evidence support an association between arterial 
stiffness and endothelial function in humans, and brachial artery endothelial 
dysfunction also correlated with increased carotid IMT [93, 140]. There is also 
evidence for the reverse association; the inability of endothelial cells to express 
NO synthase while in stiffened arteries is substantially reduced [94]. Therefore, it 
is possible that endothelial dysfunction could contribute to the early stages of 
arterial stiffness, which could then further aggravate endothelial dysfunction in a 
vicious cycle.  
We examined endothelium-dependent vasodilation, using the FMD technique. 
We discovered no significant difference in endothelial function, under basal 
conditions, between the MetS individuals and healthy controls (figure 4.6). 
However, % change in FMDflow, when normalized to FMD:SRAUC, was 30% 
lower in the MetS group, compared to the healthy controls. A greater effect was 
observed in a type II diabetic population, that had significantly lower endothelial-
dependent vasodilation, compared to healthy controls [90]. This could be 
attributed to the more advanced stage of disease in this group. When compared 
to the MetS group, the diabetic population could have more severe insulin 
resistance and structural alterations of the arterial wall. Hyperglycemia can 
contribute to defective insulin-stimulated vasodilator capacity through increased 
AGEs, formation of oxygen-derived free radicals, and disruption of the NO-VSMC 
vasodilator pathway [90]. Also, high total cholesterol (which may be significantly 
more advance in type II diabetics), not measured in our study, is associated with 
endothelial dysfunction [90].  
5.2. Effects of Training on Measures of Arterial Stiffness 
 
 
In the present study we found strong evidence that arterial stiffness decreases 
with aerobic exercise in MetS individuals, compared to their Mets counterparts 
who remained sedentary. This was observed through a significant decrease of 
almost 1 m/s in PWVcf (figure 4.7) and a tendency for AIx (figure 4.9) to 
decrease in the trained group. The 11% reduction in PWV and 20% decrease in 
AIx@75 are correlated with a significant decline in CV risk; a 1 m/s decrease in 
PWV is equivalent to a 14% reduction in risk [7]. There was no significant 
difference in HR, height, BP, or age (table 4.2) between the groups. 
Although the mechanisms underlying the association between aerobic exercise 
training and arterial stiffness are not fully understood, there are several possible 
explanations. There is strong evidence that the improvement is not linked to 
traditional risk factors, as there was no significant change in BMI or body fat %, 
hemodynamic, or metabolic parameters after the exercise intervention (table 
4.2). This suggests aerobic exercise is related to an improvement in arterial 
function, regardless of changes in metabolic risk. A major finding of this study 
was that the decrease in stiffness occurred with an increase in peak aerobic 
capacity, in the trained group. Cross-sectional analysis revealed that the MetS 
group had a significantly lower VO2peak compared to the control group (figure 
4.5). We also showed that VO2peak was negatively associated with the MRS 
(figure 4.18). In relation to CV risk, Jae’s group found that men with the MetS 
who maintain high cardiorespiratory fitness levels have a lower risk of mortality 
than unfit men without MetS [111]. It has also been shown that low aerobic 
capacity (measured as MET) is a stronger predictor of CVD and mortality than 
other established risk factors, such as hypertension, smoking, and diabetes [58]. 
The same group found that with decreasing fitness, the relative risk of death from 
all causes nearly doubled in all subgroups possessing a CV risk factor 
(hypertension, COPD, diabetes, smoking, high cholesterol, obesity). 
Lower arterial stiffness is correlated with higher levels of fitness in MetS 
individuals who have participated in life-long, more consistent, pursuit of exercise 
[111]. However, it was not known whether previously sedentary, MetS individuals 
could benefit from implementing a regular exercise regime into their lifestyle. 
Therefore, the present study provided novel evidence that participating in aerobic 
exercise effectively reduced arterial stiffness, while improving peak aerobic 
capacity. VO2peak improved by 14% in the trained group, while the non-trained 
group had no change (figure 4.11). We also supported previous studies [37] that 
composite measures of stiffness were inversely correlated with peak aerobic 
capacity, measured as VO2peak (figure 4.19).  
The link between the improvement in VO2peak and attenuation of stiffness could 
be due to a number of potential mechanisms, described further later in the 
discussion. Briefly, aerobic exercise decreases inflammation and oxidative 
stress, both elevated in the MetS, which contribute to increased arterial stiffness 
[115]. Exercise also has been shown to improve insulin sensitivity, improving 
arterial compliance and endothelial-dependent vasodilation with an increase in 
NO bioavailability [38]. Aerobic exercise can attenuate excessive sympathetic 
activity, decreasing arterial tone, improving compliance in a relatively short period 
of time [112]. Finally, it is possible that the elastin-collagen composition changed. 
The increase in pressures and mechanical distension during exercise bouts can 
stretch collagen fibers and modify their cross-linking [112]. Although it is believed 
that structural changes occur more gradually over a longer period of time. 
Conversely, it is possible that the increased arterial stiffening in individuals with 
the MetS may have directly caused the decrease in aerobic capacity. An 
increase in stiffness contributes substantially to the workload of the LV. Ejection 
of blood into a stiff aorta, coupled with early return of reflected pressure waves, 
increases cPP and cardiac energetic demand, which reduces myocardial oxygen 
supply and consumption, decreasing coronary perfusion [112]. Therefore the 
changes in fitness levels may be due to a decrease in stiffness and improvement 
in the ventricular-arterial relationship, rather than the converse relationship. 
An attenuation of endothelial dysfunction, and consequent decrease in VSMC 
tone may explain some of the reversal in stiffness after aerobic exercise training. 
The contribution of VSMCs to large artery stiffness is proportional to their level of 
active tone and effect arterial stiffness through their regulatory influence on 
distending pressure as well as by affecting the physical properties of various 
arterial wall components [4]. In a healthy endothelium, cells synthesize NO, 
which then diffuses to VSMCs causing an intracellular cascade of events. This 
leads to a decrease in tone and an increase in vasodilator capacity of the artery. 
Shear stress was determined to be a principal physiological stimulus to arterial 
adaptations associated with exercise training [43]. Tinken et al [108] placed a cuff 
around one arm, during training sessions, to produce a unilateral decrease in the 
blood flow and shear stress associated with exercise bouts. The group found that 
despite similar effects on forearm volume, girth, and strength, vasodilator 
function, measured as FMD % diameter change, improved only in the limb 
exposed to increases in shear stress [108]. Shear stress is an important stimulus 
that provokes the increase in NO release, and the consequent increase in 
vasodilator response as VSMC tone decreases. Indeed our group found that 
FMD did improve (figure 4.10) after normalizing to shear rate in the trained 
group, falling short of reaching significance. However, the shear stress provoked 
during the aerobic exercise bouts (not measured), could be responsible for some 
of the decrease in stiffness observed in our population. 
Endothelium-dependent vasodilation declines with an increase in the MRS and is 
increased in Mets individuals [142]. Our data did not show any significant 
improvement in endothelial function dependent on flow, measured with FMD, in 
the MetS trained individuals (figure 4.10). However, there was a slight 
improvement of change in post-stimulus diameter as a percentage of the 
baseline diameter, which is considered to be a more robust assessment of 
endothelial-dependent vasodilation. Although, the 21% improvement was not 
significant, a previous study, utilizing computer-assisted FMD analysis, did show 
a significant improvement in FMD after acute and chronic exercise in the MetS 
population [16]. Normalization of FMD to SRAUC has recently been proposed to 
control for the presence of the large inter-subject variability in reactive 
hyperemia-induced shear stress [143]. We observed an increase of 43% in the 
FMD response, when normalized to SRAUC. One reason that could explain why 
our subjects did not show a significant improvement in endothelial function could 
be due to the large degree of observer error associated with manual assessment 
of arterial diameters, using visual inspection of single frames [125]. Once the 
arterial image for analysis is chosen, the boundaries for diameter measurements 
(the lumen-intima interfaces) are identified manually with electronic calipers or 
automatically using edge-detection software. Computer-assisted analysis, 
utilizing edge-detected and wall-tracking software, has demonstrated significantly 
lower intra-observer variation compared to the manual technique [125]. In 
addition, a study done in type II diabetics showed an improved endothelial-
dependent vasodilation response, following exercise, compared to no change for 
healthy controls, who also participated in the exercise protocol [38]. A possible 
explanation may be related to an improved insulin sensitivity or change in total 
cholesterol. Therefore, the lack of significant change of FMD in our MetS group, 
could also be explained by the less advanced state of disease and insulin 
insensitivity, compared to type II diabetics. 
 
VSMC cell tone is also influenced by sympathetic nervous system activity [85]. 
Increased sympathetic activity and elevated levels of vasoconstrictor circulating 
factors (norepinephrine, epinephrine) are associated with depressed levels of 
NO, reducing endothelial function and increasing stiffness [144]. Also, both stiffer 
arteries and endothelial dysfunction play a role in MetS risk factors that 
contribute to baroreflex dysfunction, which tends to reinforce sympathetic outflow 
and arterial distensibility; and potentially contribute to increased tone [144]. All of 
these factors together contribute to a vicious cycle of high sympathetic outflow, 
reduced vasodilator function and increased CVD risk. Reduced HR variability, a 
measure of autonomic balance, was associated with an increase incidence of 
CAD, myocardial infarction, and fatal heart disease and total mortality in a 
diabetic population [144]. 
There is strong evidence to suggest that exercise training can keep the 
autonomic nervous system healthy, and arterial compliance can be altered in a 
short period of time with exercise, via modulation of sympathetic influence of 
VSMCs [112]. In both middle-aged and older subjects the baroreflex function was 
worse in most sedentary subjects compared to those who participate in moderate 
exercise, and better yet in those who perform regular endurance exercise [144]. 
Thijssen et al [145] showed that acute changes in arterial tone altered both 
femoral and carotid IMT after acute administration of glyceryl trinitrate, a NO 
donor that improves vasodilation through VSMC relaxation. This suggests that 
changes in sympathetic activity may contribute to changes in arterial wall 
thickness. However, it is currently unknown whether changes in autonomic 
balance and IMT as a result of chronic exercise training are correlated. 
Unfortunately, sympathetic activity was not measured in our study; therefore we 
can only theorize that the same influence of VSMC on elasticity occurred.  
It is not known if short-term exercise interventions alter the structural composition 
in the arterial wall. However, it is possible that the increased shear stress and 
mechanical distension during exercise modify collagen fiber cross-linking, 
thereby arterial elasticity [112]. As explained earlier, changes in large artery 
compliance following an aerobic exercise intervention are relatively rapid and 
may be more heavily impacted by functional change. The increase in stiffness, 
and rise in cPP, increases the risk of carotid thickening, in response to insults via 
hyperplasia and hypertrophy of VMSC and increased collagen deposition [69]. 
We showed that composite measures of stiffness were strongly correlated with 
both IMTavg and IMTmax (figure 4.15 and 4.16). Following repetitive systolic 
stretching, the elastic lamellae become more disorganized, collagen content 
increases, VSMC hypertrophy and AGEs form degrading cross-links with elastin 
content, contributing to the increase in thickening [146]. This process occurs with 
age, and is often accelerated in a diseased state. Our study discovered no 
change in carotid IMT after 8 weeks of aerobic exercise training (figure 4.8).  
Previous studies have proven to be inconclusive on whether an exercise 
intervention can attenuate IMT in either the carotid or peripheral sites. Thijssen et 
al [2] found a significant decrease in brachial wall thickness following 8 weeks of 
handgrip exercise. Another group revealed a significantly lower superficial 
femoral, brachial, and most relevant, carotid artery wall thickness in squash 
athletes compared to sedentary, healthy controls [44]. Tanaka et al [45] showed 
an increase in carotid IMT with increasing age, in both sedentary and endurance-
trained healthy men. Within the same group, 18 healthy middle-aged and older 
sedentary subjects participated in 3 months of aerobic exercise (4-6 days a week 
for 45 minutes) and saw no change in carotid IMT [45]. Other studies reported an 
inverse relationship between VO2peak and carotid IMT [147, 148]. Therefore, it 
was our hypothesis that exercise intervention in a diseased population that 
experiences more advanced carotid IMT, would show some attenuation of wall 
remodeling. We believe the lack of attenuation in distending pressure may be 
linked to the IMT observations. Both cPP (figure 4.16) and cSBP showed a 
strong relationship with average and maximum carotid IMT. This was also 
confirmed in a previous study of a healthy population [45]. The absence of 
reductions in carotid IMT with exercise intervention was accompanied by a 
corresponding absence of reduction in carotid SBP and PP (table 4.2). Future 
aerobic interventions, with increased sessions of a prolonged nature, may 
provide different results of action on central pressure indices and arterial wall 
remodeling in the MetS.  
Several other mechanisms are probably involved and require further 
investigation; we attempt to enumerate upon them, without an in-depth 
discussion. These may include alterations in other vasodilator factors 
(prostaglandins, hyperpolarizing factor), vasoconstrictor molecules (endothelin-1 
and angiotensin II), inflammatory mediators, reactive oxygen species and anti-
oxidant defenses; which can all influence VSMC tone and remodeling [142]. In 
addition to the improved endothelial dysfunction observed after aerobic exercise, 
Tjonna et al [16] also showed a reduction in oxidized LDL, which directly 
influences NO bioavailability, and an significant increase in adiponectin. High 
fitness is associated with low levels of MetS risk factors, abdominal fat, insulin 
resistance, inflammation, oxidative stress, and BP all of which are independently 
associated with increased arterial stiffness [111]. Both insulin resistance and 
inflammation have been shown to be associated with endothelial dysfunction and 
wall thickening, which may increase arterial stiffening [43]. BP was not improved 
in our group, and insulin resistance or inflammation was not measured. 
We also theorize that a decrease in insulin sensitivity and improved fatty acid 
oxidation, taken together with reduced plasma oxidized LDL levels, could result 
in a positive influence on arterial function. Adipocytes, in particular from visceral 
abdominal regions, produce several bioactive peptides, such as angiotensin, 
interleukin-6, plasminogen activator inhibitor-1, leptin and adiponectin, which in 
turn impact on arterial structure and function [149]. Elevated leptin and low 
adiponectin levels are commonly found in association with the MetS and have 
been associated with endothelial dysfunction and arterial stiffening in the MetS 
[149]. Conversely, adiponectin stimulates NO production, reducing expression of 
adhesion molecules and cytokine production [149]. Adiponectin levels increase 
with exercise, inhibiting markers of inflammation, improving arterial compliance 
[149]. As presented earlier, 86% of our MetS population met the waist 
circumference inclusion criteria and on average had an obese BMI of 37 (table 
4.1). This increase in abdominal obesity could correlate with an increase in leptin 
and decrease in adiponectin. In addition, metabolic toxins, such as free fatty 
acids and inflammatory cytokines, including interleukin-6 and tumor necrosis 
factor-alpha, might alter endothelial signaling pathways, such as the PI3K–Akt 
pathway, increasing VSMC tone [84]. Future interventions incorporating the use 
of biomarker assessment, in relation to arterial stiffness, could discover some of 
the before mentioned possibilities of mechanistic changes. 
 
1.4. Limitations of the Study 
 
 
Because our exercise intervention was completed by a relatively small number of 
subjects, the benefits of aerobic training on arterial stiffness need to be confirmed 
by larger studies. The fact that a short 8-week intervention produced a sizable 
decrease in arterial stiffness suggests that larger exercise studies, of longer 
duration, in this high-risk group may attenuate measures of arterial remodeling. 
 
The method used to measure FMD was prone to a larger degree of observer 
error compared to the computerized diagnostic program. Future use of the 
computerized method could improve the endothelial-dependent response 
reliability. In addition, shear rate measured during an acute bout of exercise 
could determine the role on improved endothelial function. 
 
Neurohumoral, inflammatory, oxidative, and metabolic biomarkers can directly 
influence arterial stiffness and wall remodeling. However, the improvements 
observed in the MetS trained group cannot be pinpointed to a specific 
mechanism and future studies should therefore incorporate some of these 
procedures. 
Finally, the time-dependent relation between increased cPP and arterial 
remodeling could not be determined in the present study because of its cross-
sectional design. 
	  	  
	  
 
 
 
Chapter 6 
 
 
 
 
Conclusions 
 
 
 
 
The purpose of this thesis was to examine the impact of aerobic exercise training 
on arterial stiffness and wall remodeling in individuals with the MetS. Arterial 
dysfunction, due in part to arterial stiffening, is recognized as a surrogate end 
point for CVD and predicts the risk of future CV events. The MetS is a clustering 
of risk factors associated with increased stiffening and carotid artery thickening. 
Aerobic exercise is a well-established therapy that reduces CV morbidity and 
mortality and has proven to be an effective intervention against arterial stiffening 
and pathological wall remodeling in healthy, previously sedentary, individuals and 
other diseased populations [12]. However, no study had examined the effect of 
chronic aerobic exercise on arterial stiffness or remodeling in MetS individuals.  
In our study, the PWVcf and cPP were 26% and 33% higher, respectively, in 
MetS individuals compared to controls. Carotid IMT was 13% greater in the MetS 
group. The major finding of this study was that 8 weeks of aerobic exercise 
significantly attenuated measures of arterial stiffness in the trained MetS 
individuals, but did not have an effect on carotid IMT. Another important 
discovery was the 14% improvement in VO2peak in the trained population, 
compared to no change for the non-trained group.  
The results described in this thesis have progressed the understanding of 
aerobic exercise as an effective therapeutic intervention for the arterial stiffening 
observed in the MetS. Although it was out of our scope to directly measure the 
mechanistic changes that are responsible for the improvement in arterial 
compliance, our data supports the theory that the changes associated with an 
improvement in peak aerobic capacity may facilitate these developments. 
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